query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_0141_ESMFold_hypothetical_protein	4ww9-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4ww9-assembly1.cif.gz_A Crystal structure of binary complex Bud32-Cgi121 in complex with ADP	0.160	227	187	35	261	15	238	5.094E-07	205
LOKIASV2_0141_ESMFold_hypothetical_protein	4ww7-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4ww7-assembly1.cif.gz_A Crystal structure of binary complex Bud32-Cgi121 in complex with AMP	0.154	220	183	35	251	15	234	1.803E-06	191
LOKIASV2_0141_ESMFold_hypothetical_protein	2pup-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2pup-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.118	351	243	9	284	6	356	3.575E-06	188
LOKIASV2_0141_ESMFold_hypothetical_protein	2pul-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2pul-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.118	333	219	36	284	22	354	1.710E-06	187
LOKIASV2_0141_ESMFold_hypothetical_protein	2pul-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2pul-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.118	361	245	6	284	6	366	2.896E-06	187
LOKIASV2_0141_ESMFold_hypothetical_protein	2pun-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2pun-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.118	359	243	9	284	7	365	2.346E-06	186
LOKIASV2_0141_ESMFold_hypothetical_protein	2pun-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2pun-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.122	353	234	17	284	11	363	1.900E-06	183
LOKIASV2_0141_ESMFold_hypothetical_protein	4wwa-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4wwa-assembly1.cif.gz_A Crystal structure of binary complex Bud32-Cgi121	0.160	242	175	35	276	15	223	2.473E-06	182
LOKIASV2_0141_ESMFold_hypothetical_protein	2pyw-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2pyw-assembly1.cif.gz_A Structure of A. thaliana 5-methylthioribose kinase in complex with ADP and MTR	0.093	400	251	7	284	5	404	6.053E-06	182
LOKIASV2_0141_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_B Structure of Mnk1 in complex with DS12881479	0.157	204	162	26	218	5	208	4.903E-06	178
LOKIASV2_0141_ESMFold_hypothetical_protein	2olc-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2olc-assembly1.cif.gz_B Crystal structure of 5-methylthioribose kinase in complex with ADP-2Ho	0.121	353	238	13	284	9	361	3.392E-06	178
LOKIASV2_0141_ESMFold_hypothetical_protein	1zth-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	1zth-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.137	216	180	9	218	29	244	7.876E-06	177
LOKIASV2_0141_ESMFold_hypothetical_protein	1zar-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	1zar-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio2 Kinase Complexed With ADP and Manganese Ions	0.133	203	165	15	217	76	266	3.392E-06	177
LOKIASV2_0141_ESMFold_hypothetical_protein	2pui-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2pui-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.119	338	233	9	274	5	342	1.025E-05	174
LOKIASV2_0141_ESMFold_hypothetical_protein	2pu8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2pu8-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.122	342	219	35	284	17	358	3.972E-06	174
LOKIASV2_0141_ESMFold_hypothetical_protein	6sul-assembly2.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	6sul-assembly2.cif.gz_D Amicoumacin kinase AmiN in complex with AMP-PNP, Mg2+ and Ami	0.137	313	225	13	274	6	318	3.052E-06	171
LOKIASV2_0141_ESMFold_hypothetical_protein	2olc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2olc-assembly1.cif.gz_A Crystal structure of 5-methylthioribose kinase in complex with ADP-2Ho	0.124	346	235	6	274	6	351	4.652E-06	170
LOKIASV2_0141_ESMFold_hypothetical_protein	2pu8-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2pu8-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.109	330	222	35	284	21	350	7.876E-06	169
LOKIASV2_0141_ESMFold_hypothetical_protein	2pui-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2pui-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.124	335	218	35	284	19	353	1.139E-05	167
LOKIASV2_0141_ESMFold_hypothetical_protein	1zao-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	1zao-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio2 Kinase Complexed With ATP and Manganese Ions	0.129	204	168	15	218	77	270	8.302E-06	166
LOKIASV2_0141_ESMFold_hypothetical_protein	1zth-assembly4.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	1zth-assembly4.cif.gz_D Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.131	210	178	12	217	34	243	1.334E-05	165
LOKIASV2_0141_ESMFold_hypothetical_protein	4f99-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4f99-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and nucleotide	0.121	169	142	13	181	2	164	1.200E-05	165
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdn-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6fdn-assembly1.cif.gz_A Rio2 structure	0.157	183	145	14	196	42	214	3.823E-05	164
LOKIASV2_0141_ESMFold_hypothetical_protein	1ztf-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	1ztf-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio1 serine protein kinase	0.123	240	186	5	217	13	252	7.876E-06	164
LOKIASV2_0141_ESMFold_hypothetical_protein	1zth-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	1zth-assembly3.cif.gz_C Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.130	207	179	12	218	34	240	1.735E-05	163
LOKIASV2_0141_ESMFold_hypothetical_protein	4dca-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4dca-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-Ib, ADP-bound	0.146	291	223	14	275	4	294	2.111E-06	162
LOKIASV2_0141_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	0.169	156	126	29	181	14	169	6.824E-05	161
LOKIASV2_0141_ESMFold_hypothetical_protein	3re4-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3re4-assembly1.cif.gz_A Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase bound to Toyocamycin.	0.130	217	175	17	218	35	251	2.032E-05	160
LOKIASV2_0141_ESMFold_hypothetical_protein	2j5f-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2j5f-assembly1.cif.gz_A Crystal structure of EGFR kinase domain in complex with an irreversible inhibitor 34-jab	0.138	192	165	28	219	16	207	3.768E-06	160
LOKIASV2_0141_ESMFold_hypothetical_protein	7up8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7up8-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	0.153	194	158	25	218	6	192	7.876E-06	159
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdn-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6fdn-assembly1.cif.gz_B Rio2 structure	0.145	178	141	19	196	69	234	6.474E-05	158
LOKIASV2_0141_ESMFold_hypothetical_protein	3ad6-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3ad6-assembly1.cif.gz_A Crystal structure of Pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-phosphorylated on TYR394)	0.161	156	124	26	181	13	161	2.258E-05	158
LOKIASV2_0141_ESMFold_hypothetical_protein	4j99-assembly5.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4j99-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.161	198	164	28	223	15	212	4.413E-06	158
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdm-assembly2.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	6fdm-assembly2.cif.gz_D Human Rio2 kinase structure	0.142	213	177	12	218	66	278	7.089E-06	158
LOKIASV2_0141_ESMFold_hypothetical_protein	3re4-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3re4-assembly2.cif.gz_B Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase bound to Toyocamycin.	0.137	212	172	17	216	35	246	3.265E-05	157
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdo-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6fdo-assembly2.cif.gz_B Rio2 structure	0.155	216	174	12	218	65	280	1.562E-05	157
LOKIASV2_0141_ESMFold_hypothetical_protein	7vbt-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7vbt-assembly1.cif.gz_A Crystal structure of RIOK2 in complex with CQ211	0.149	216	175	12	218	74	289	9.723E-06	157
LOKIASV2_0141_ESMFold_hypothetical_protein	1zth-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	1zth-assembly2.cif.gz_B Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.136	214	182	7	218	27	240	5.168E-06	156
LOKIASV2_0141_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.153	193	152	21	213	6	186	1.928E-05	156
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdm-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6fdm-assembly2.cif.gz_C Human Rio2 kinase structure	0.147	212	176	12	218	70	281	1.928E-05	154
LOKIASV2_0141_ESMFold_hypothetical_protein	2pup-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2pup-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.120	339	226	17	274	7	345	4.720E-05	154
LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly4.cif.gz_G	LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly4.cif.gz_G Human RIOK2 bound to inhibitor	0.151	189	149	14	202	69	245	6.142E-05	153
LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly5.cif.gz_H	LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly5.cif.gz_H Human RIOK2 bound to inhibitor	0.160	191	151	12	202	75	255	4.975E-05	153
LOKIASV2_0141_ESMFold_hypothetical_protein	3hav-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	3hav-assembly3.cif.gz_C Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.129	276	225	13	271	7	282	1.482E-05	153
LOKIASV2_0141_ESMFold_hypothetical_protein	3hav-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3hav-assembly2.cif.gz_B Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.133	258	199	13	242	7	264	2.142E-05	153
LOKIASV2_0141_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_D Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.156	198	162	28	220	14	211	9.723E-06	152
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6fdm-assembly1.cif.gz_A Human Rio2 kinase structure	0.149	213	175	12	218	70	282	4.030E-05	152
LOKIASV2_0141_ESMFold_hypothetical_protein	5uxb-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5uxb-assembly1.cif.gz_A Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	0.116	282	223	20	272	4	285	2.509E-05	152
LOKIASV2_0141_ESMFold_hypothetical_protein	3hav-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3hav-assembly1.cif.gz_A Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.136	282	225	13	273	7	288	1.406E-05	152
LOKIASV2_0141_ESMFold_hypothetical_protein	2ity-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2ity-assembly1.cif.gz_A Crystal structure of EGFR kinase domain in complex with Iressa	0.128	245	179	28	233	15	259	7.472E-06	152
LOKIASV2_0141_ESMFold_hypothetical_protein	5uxa-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5uxa-assembly1.cif.gz_A Crystal structure of macrolide 2'-phosphotransferase MphB from Escherichia coli	0.125	296	227	13	272	2	297	6.053E-06	152
LOKIASV2_0141_ESMFold_hypothetical_protein	4yju-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4yju-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000249	0.117	242	207	28	269	6	240	2.346E-06	151
LOKIASV2_0141_ESMFold_hypothetical_protein	4yjt-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4yjt-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000233	0.118	241	169	28	220	6	246	8.751E-06	151
LOKIASV2_0141_ESMFold_hypothetical_protein	4g2f-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4g2f-assembly1.cif.gz_A Human EphA3 kinase domain in complex with compound 7	0.114	255	223	28	282	12	264	3.218E-06	151
LOKIASV2_0141_ESMFold_hypothetical_protein	5mjb-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5mjb-assembly1.cif.gz_A Kinase domain of human EphB1, G703C mutant, covalently bound to a quinazoline-based inhibitor	0.128	194	146	28	196	11	204	1.562E-05	151
LOKIASV2_0141_ESMFold_hypothetical_protein	7uiq-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7uiq-assembly2.cif.gz_B Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and Tiam1	0.144	154	126	28	181	5	152	1.426E-04	150
LOKIASV2_0141_ESMFold_hypothetical_protein	5cy3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5cy3-assembly1.cif.gz_A SYK catalytic domain complexed with a potent and orally bioavailable benzisothiazole inhibitor	0.117	266	223	28	281	10	275	1.623E-06	150
LOKIASV2_0141_ESMFold_hypothetical_protein	3kn5-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3kn5-assembly2.cif.gz_B Crystal structure of the C-terminal kinase domain of msk1 in complex with AMP-PNP	0.148	181	148	25	205	6	180	8.879E-05	150
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdm-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6fdm-assembly1.cif.gz_B Human Rio2 kinase structure	0.147	212	176	12	218	64	275	3.097E-05	149
LOKIASV2_0141_ESMFold_hypothetical_protein	2vx3-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	2vx3-assembly3.cif.gz_C Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1A	0.147	155	131	28	181	24	178	2.174E-04	149
LOKIASV2_0141_ESMFold_hypothetical_protein	4ix3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4ix3-assembly1.cif.gz_A Crystal structure of a Stt7 homolog from Micromonas algae	0.134	173	129	28	177	20	192	1.426E-04	149
LOKIASV2_0141_ESMFold_hypothetical_protein	2hw6-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2hw6-assembly2.cif.gz_B Crystal structure of Mnk1 catalytic domain	0.139	179	141	29	193	9	187	1.284E-04	148
LOKIASV2_0141_ESMFold_hypothetical_protein	4li5-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4li5-assembly1.cif.gz_A EGFR-K IN COMPLEX WITH N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-phenyl] Prop-2-enamide	0.130	261	184	28	239	19	279	9.224E-06	148
LOKIASV2_0141_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.154	242	195	28	269	14	244	2.346E-06	147
LOKIASV2_0141_ESMFold_hypothetical_protein	4xg6-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4xg6-assembly1.cif.gz_A Crystal structure of an inhibitor-bound Syk	0.118	264	222	28	280	7	270	1.539E-06	147
LOKIASV2_0141_ESMFold_hypothetical_protein	4e20-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4e20-assembly1.cif.gz_A Structure of mouse Tyk-2 complexed to a 3-aminoindazole inhibitor	0.149	250	202	34	271	8	257	3.052E-06	147
LOKIASV2_0141_ESMFold_hypothetical_protein	2qoc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2qoc-assembly1.cif.gz_A Human EphA3 kinase domain, phosphorylated, AMP-PNP bound structure	0.126	264	221	31	284	4	267	8.183E-07	147
LOKIASV2_0141_ESMFold_hypothetical_protein	5ugl-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ugl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	0.157	227	177	28	238	13	239	6.380E-06	147
LOKIASV2_0141_ESMFold_hypothetical_protein	7up5-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7up5-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 23 (co-crystal)	0.146	181	147	25	205	6	178	6.142E-05	147
LOKIASV2_0141_ESMFold_hypothetical_protein	3kul-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3kul-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 8 (EPHA8)	0.119	195	169	28	220	8	202	2.645E-05	146
LOKIASV2_0141_ESMFold_hypothetical_protein	3kul-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3kul-assembly2.cif.gz_B Kinase domain of human ephrin type-A receptor 8 (EPHA8)	0.121	201	169	28	220	8	208	2.142E-05	146
LOKIASV2_0141_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.170	220	174	28	238	14	233	4.903E-06	146
LOKIASV2_0141_ESMFold_hypothetical_protein	5gmp-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5gmp-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 T790M in complex with XTF-262	0.144	197	166	31	227	12	206	5.448E-06	146
LOKIASV2_0141_ESMFold_hypothetical_protein	4xg7-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4xg7-assembly1.cif.gz_A Crystal structure of an inhibitor-bound Syk	0.105	264	223	31	280	2	265	5.168E-06	145
LOKIASV2_0141_ESMFold_hypothetical_protein	6in0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6in0-assembly1.cif.gz_A Crystal structure of EphA3 in complex with 18-Crown-6	0.125	258	220	31	282	4	261	1.460E-06	145
LOKIASV2_0141_ESMFold_hypothetical_protein	7up4-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7up4-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	0.127	192	158	25	206	6	197	2.788E-05	145
LOKIASV2_0141_ESMFold_hypothetical_protein	7vbt-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7vbt-assembly1.cif.gz_B Crystal structure of RIOK2 in complex with CQ211	0.150	212	175	12	218	70	281	4.478E-05	145
LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly4.cif.gz_J	LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly4.cif.gz_J Human RIOK2 bound to inhibitor	0.158	189	157	14	202	78	264	9.865E-05	145
LOKIASV2_0141_ESMFold_hypothetical_protein	7vnx-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7vnx-assembly1.cif.gz_A Crystal structure of TkArkI	0.153	269	180	1	269	1	214	2.938E-05	144
LOKIASV2_0141_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_A Structure of Mnk1 in complex with DS12881479	0.142	232	178	26	234	5	236	7.992E-05	144
LOKIASV2_0141_ESMFold_hypothetical_protein	2pyw-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2pyw-assembly1.cif.gz_B Structure of A. thaliana 5-methylthioribose kinase in complex with ADP and MTR	0.100	338	240	7	274	6	343	2.938E-05	144
LOKIASV2_0141_ESMFold_hypothetical_protein	2bkk-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2bkk-assembly1.cif.gz_A Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	0.132	237	176	22	225	9	245	2.938E-05	143
LOKIASV2_0141_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	0.144	271	223	17	277	2	272	3.575E-06	143
LOKIASV2_0141_ESMFold_hypothetical_protein	4p5q-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4p5q-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with quinoxaline derivatives	0.126	259	221	31	284	8	266	3.972E-06	143
LOKIASV2_0141_ESMFold_hypothetical_protein	3ri1-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3ri1-assembly1.cif.gz_A Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	0.137	272	216	28	278	13	284	3.052E-06	143
LOKIASV2_0141_ESMFold_hypothetical_protein	6g3c-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6g3c-assembly2.cif.gz_B Crystal Structure of JAK2-V617F pseudokinase domain in complex with Compound 2	0.152	239	175	28	234	8	246	2.226E-06	142
LOKIASV2_0141_ESMFold_hypothetical_protein	3lm5-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3lm5-assembly1.cif.gz_A Crystal Structure of human Serine/Threonine Kinase 17B (STK17B) in complex with Quercetin	0.131	252	202	22	273	8	241	8.751E-06	142
LOKIASV2_0141_ESMFold_hypothetical_protein	7t1t-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7t1t-assembly1.cif.gz_A JAK2 JH2 IN COMPLEX WITH JAK292	0.162	206	166	28	226	9	214	1.829E-05	142
LOKIASV2_0141_ESMFold_hypothetical_protein	7up7-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7up7-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	0.117	273	200	23	250	4	276	7.472E-06	142
LOKIASV2_0141_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_C Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.144	260	211	28	274	14	273	3.218E-06	142
LOKIASV2_0141_ESMFold_hypothetical_protein	4j99-assembly6.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	4j99-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.155	262	208	28	274	16	277	3.768E-06	142
LOKIASV2_0141_ESMFold_hypothetical_protein	5l6w-assembly1.cif.gz_L	LOKIASV2_0141_ESMFold_hypothetical_protein	5l6w-assembly1.cif.gz_L Structure Of the LIMK1-ATPgammaS-CFL1 Complex	0.114	279	219	28	275	11	289	3.823E-05	142
LOKIASV2_0141_ESMFold_hypothetical_protein	7uyw-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7uyw-assembly1.cif.gz_A Crystal structure of JAK2 kinase domain in complex with compound 30	0.134	280	208	34	274	6	285	3.052E-06	142
LOKIASV2_0141_ESMFold_hypothetical_protein	7ozy-assembly2.cif.gz_BBB	LOKIASV2_0141_ESMFold_hypothetical_protein	7ozy-assembly2.cif.gz_BBB FGFR2 kinase domain (residues 461-763) in complex with 38.	0.143	244	207	28	271	14	256	4.903E-06	141
LOKIASV2_0141_ESMFold_hypothetical_protein	5i9v-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5i9v-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with AGS	0.140	194	163	31	220	4	197	1.482E-05	141
LOKIASV2_0141_ESMFold_hypothetical_protein	7ju5-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7ju5-assembly1.cif.gz_A Structure of RET protein tyrosine kinase in complex with pralsetinib	0.127	263	218	28	278	24	286	2.747E-06	141
LOKIASV2_0141_ESMFold_hypothetical_protein	7kia-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7kia-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	0.130	250	211	28	271	14	263	5.168E-06	141
LOKIASV2_0141_ESMFold_hypothetical_protein	5ih0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ih0-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II Y92M mutant - complex with GDP and erythromycin	0.125	296	197	13	238	3	298	8.751E-06	141
LOKIASV2_0141_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2	LOKIASV2_0141_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2 ASK1 kinase domain in complex with Compound 11	0.197	214	145	35	215	2	215	4.975E-05	140
LOKIASV2_0141_ESMFold_hypothetical_protein	4yjp-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4yjp-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000223	0.110	257	221	28	276	6	262	5.168E-06	140
LOKIASV2_0141_ESMFold_hypothetical_protein	4xg9-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4xg9-assembly2.cif.gz_B Crystal structure of an inhibitor-bound Syk	0.119	258	220	28	278	7	264	4.187E-06	140
LOKIASV2_0141_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.142	179	147	35	213	1	172	7.582E-05	140
LOKIASV2_0141_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_C Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.167	223	175	28	238	13	235	1.735E-05	140
LOKIASV2_0141_ESMFold_hypothetical_protein	2ivv-assembly1.cif.gz_A-2	LOKIASV2_0141_ESMFold_hypothetical_protein	2ivv-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor PP1	0.125	278	230	11	274	3	280	2.896E-06	140
LOKIASV2_0141_ESMFold_hypothetical_protein	6fdo-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6fdo-assembly1.cif.gz_A Rio2 structure	0.127	216	180	12	218	66	281	8.879E-05	140
LOKIASV2_0141_ESMFold_hypothetical_protein	3b2t-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3b2t-assembly1.cif.gz_B Structure of phosphotransferase	0.154	269	179	29	241	17	285	5.743E-06	140
LOKIASV2_0141_ESMFold_hypothetical_protein	3o0g-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3o0g-assembly1.cif.gz_A Crystal Structure of Cdk5:p25 in complex with an ATP analogue	0.169	151	122	34	181	2	152	1.585E-04	140
LOKIASV2_0141_ESMFold_hypothetical_protein	5igw-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5igw-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II - complex with GDP and clarithromycin	0.125	291	194	13	235	2	292	9.723E-06	140
LOKIASV2_0141_ESMFold_hypothetical_protein	5x27-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5x27-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 L858R in complex with SKLB(5)	0.123	256	221	28	280	15	270	4.903E-06	140
LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly6.cif.gz_F	LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly6.cif.gz_F HER2 in complex with JBJ-08-178-01	0.147	193	156	28	220	7	190	1.829E-05	139
LOKIASV2_0141_ESMFold_hypothetical_protein	7q7c-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7q7c-assembly1.cif.gz_A Room temperature structure of the human Serine/Threonine Kinase 17B (STK17B/DRAK2) in complex with ADP at atmospheric pressure	0.138	257	220	22	277	8	264	8.751E-06	139
LOKIASV2_0141_ESMFold_hypothetical_protein	4gk3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4gk3-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 87	0.119	252	219	28	277	12	263	5.448E-06	139
LOKIASV2_0141_ESMFold_hypothetical_protein	7dhl-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7dhl-assembly1.cif.gz_A Crystal structure of FGFR3 in complex with pyrimidine derivative	0.146	277	213	28	277	12	288	3.392E-06	139
LOKIASV2_0141_ESMFold_hypothetical_protein	3ham-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3ham-assembly1.cif.gz_A Structure of the gentamicin-APH(2")-IIa complex	0.137	283	223	13	271	7	289	4.652E-06	139
LOKIASV2_0141_ESMFold_hypothetical_protein	2itz-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2itz-assembly1.cif.gz_A Crystal structure of EGFR kinase domain L858R mutation in complex with Iressa	0.121	248	216	28	274	15	262	4.187E-06	139
LOKIASV2_0141_ESMFold_hypothetical_protein	4rss-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4rss-assembly1.cif.gz_A Crystal structure of tyrosine-protein kinase SYK with an inhibitor	0.119	263	220	28	278	6	268	6.053E-06	138
LOKIASV2_0141_ESMFold_hypothetical_protein	5uhn-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5uhn-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	0.149	256	208	28	272	12	267	6.380E-06	138
LOKIASV2_0141_ESMFold_hypothetical_protein	5uir-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5uir-assembly1.cif.gz_A Crystal structure of IRAK4 in complex with compound 11	0.160	267	223	8	274	6	271	1.406E-05	138
LOKIASV2_0141_ESMFold_hypothetical_protein	2pz5-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2pz5-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549T Mutation Responsible for Pfeiffer Syndrome	0.128	265	181	34	241	12	276	1.482E-05	138
LOKIASV2_0141_ESMFold_hypothetical_protein	7up4-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7up4-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	0.136	280	220	25	280	6	285	8.751E-06	138
LOKIASV2_0141_ESMFold_hypothetical_protein	6lvm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6lvm-assembly1.cif.gz_A Crystal structure of FGFR3 in complex with pyrimidine derivative	0.152	276	211	28	277	12	287	2.473E-06	138
LOKIASV2_0141_ESMFold_hypothetical_protein	5flf-assembly4.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	5flf-assembly4.cif.gz_D DISEASE LINKED MUTATION IN FGFR	0.154	272	179	28	239	13	284	1.265E-05	138
LOKIASV2_0141_ESMFold_hypothetical_protein	4lrm-assembly5.cif.gz_E	LOKIASV2_0141_ESMFold_hypothetical_protein	4lrm-assembly5.cif.gz_E EGFR D770_N771insNPG in complex with PD168393	0.115	264	218	28	274	15	278	7.472E-06	138
LOKIASV2_0141_ESMFold_hypothetical_protein	6zxf-assembly1.cif.gz_z	LOKIASV2_0141_ESMFold_hypothetical_protein	6zxf-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State G	0.141	277	230	1	269	21	297	8.424E-05	138
LOKIASV2_0141_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.177	228	152	35	220	2	229	4.975E-05	137
LOKIASV2_0141_ESMFold_hypothetical_protein	5uor-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5uor-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.204	207	153	35	227	3	209	2.509E-05	137
LOKIASV2_0141_ESMFold_hypothetical_protein	2ivu-assembly1.cif.gz_A-2	LOKIASV2_0141_ESMFold_hypothetical_protein	2ivu-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor ZD6474	0.136	266	215	28	277	23	288	7.876E-06	137
LOKIASV2_0141_ESMFold_hypothetical_protein	4ll0-assembly2.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4ll0-assembly2.cif.gz_A EGFR L858R/T790M in complex with PD168393	0.121	248	185	28	239	15	262	1.334E-05	137
LOKIASV2_0141_ESMFold_hypothetical_protein	3fi8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3fi8-assembly1.cif.gz_A Crystal structure of choline kinase from Plasmodium Falciparum, PF14_0020	0.122	315	219	32	281	24	338	1.562E-05	137
LOKIASV2_0141_ESMFold_hypothetical_protein	4d4v-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4d4v-assembly2.cif.gz_B Focal Adhesion Kinase catalytic domain	0.131	251	213	28	278	7	252	1.139E-05	136
LOKIASV2_0141_ESMFold_hypothetical_protein	2bkk-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	2bkk-assembly2.cif.gz_C Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	0.136	259	188	6	224	1	259	3.441E-05	136
LOKIASV2_0141_ESMFold_hypothetical_protein	8ex2-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8ex2-assembly1.cif.gz_A Crystal structure of JAK2 JH2 (pseudokinase domain) in complex with HTSA3	0.152	247	206	28	274	9	252	1.025E-05	136
LOKIASV2_0141_ESMFold_hypothetical_protein	5i4n-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5i4n-assembly1.cif.gz_A Crystal Structure of the E596A V617F Mutant JAK2 Pseudokinase Domain Bound to Mg-ATP	0.138	267	208	34	275	7	273	4.903E-06	136
LOKIASV2_0141_ESMFold_hypothetical_protein	3lm0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3lm0-assembly1.cif.gz_A Crystal Structure of human Serine/Threonine Kinase 17B (STK17B)	0.133	253	207	22	274	8	247	1.406E-05	136
LOKIASV2_0141_ESMFold_hypothetical_protein	7du8-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7du8-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Selpercatinib	0.135	277	225	17	277	2	278	6.380E-06	136
LOKIASV2_0141_ESMFold_hypothetical_protein	5uhn-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5uhn-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	0.136	267	213	28	274	12	278	5.448E-06	136
LOKIASV2_0141_ESMFold_hypothetical_protein	3bce-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	3bce-assembly3.cif.gz_C Crystal structure of the ErbB4 kinase	0.121	265	198	28	253	15	279	2.258E-05	136
LOKIASV2_0141_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_A Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.143	247	210	28	274	15	260	7.876E-06	136
LOKIASV2_0141_ESMFold_hypothetical_protein	5lqf-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5lqf-assembly1.cif.gz_A CDK1/CyclinB1/CKS2 in complex with NU6102	0.151	152	127	28	179	6	155	2.683E-04	136
LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly2.cif.gz_F	LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly2.cif.gz_F Human RIOK2 bound to inhibitor	0.140	210	157	14	223	77	260	4.248E-05	136
LOKIASV2_0141_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_B Human PRPF4B bound to benzothiophene inhibitor 224	0.136	227	191	8	234	3	224	3.627E-05	136
LOKIASV2_0141_ESMFold_hypothetical_protein	5ugl-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5ugl-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	0.146	254	210	28	274	14	267	5.168E-06	135
LOKIASV2_0141_ESMFold_hypothetical_protein	6x8f-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6x8f-assembly1.cif.gz_A Crystal structure of TYK2 with Compound 11	0.117	243	206	38	271	15	257	1.928E-05	135
LOKIASV2_0141_ESMFold_hypothetical_protein	6lvl-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6lvl-assembly2.cif.gz_B Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative	0.148	249	207	28	271	13	261	9.723E-06	135
LOKIASV2_0141_ESMFold_hypothetical_protein	7kia-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7kia-assembly2.cif.gz_B Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	0.126	274	220	28	280	14	287	7.472E-06	135
LOKIASV2_0141_ESMFold_hypothetical_protein	4lrm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4lrm-assembly1.cif.gz_A EGFR D770_N771insNPG in complex with PD168393	0.135	205	172	28	227	16	220	2.938E-05	135
LOKIASV2_0141_ESMFold_hypothetical_protein	4yjv-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4yjv-assembly1.cif.gz_A THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH GTC000250	0.127	240	165	31	220	2	241	2.032E-05	134
LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly8.cif.gz_H	LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly8.cif.gz_H Crystal structure of EphB1	0.126	255	221	28	282	8	261	1.080E-05	134
LOKIASV2_0141_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.163	268	178	28	241	13	280	2.142E-05	134
LOKIASV2_0141_ESMFold_hypothetical_protein	6o95-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6o95-assembly3.cif.gz_C Structure of the IRAK4 kinase domain with compound 41	0.148	278	225	10	274	8	285	1.928E-05	134
LOKIASV2_0141_ESMFold_hypothetical_protein	1ung-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	1ung-assembly1.cif.gz_A Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.	0.180	148	120	34	181	2	148	2.415E-04	134
LOKIASV2_0141_ESMFold_hypothetical_protein	8wtf-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8wtf-assembly1.cif.gz_A The Crystal Structure of IRAK4 from Biortus	0.138	281	226	12	274	10	290	1.025E-05	134
LOKIASV2_0141_ESMFold_hypothetical_protein	6zxd-assembly1.cif.gz_z	LOKIASV2_0141_ESMFold_hypothetical_protein	6zxd-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State F1	0.135	269	227	4	266	22	290	7.193E-05	134
LOKIASV2_0141_ESMFold_hypothetical_protein	5nk0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5nk0-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1j	0.138	190	161	31	220	7	194	3.441E-05	133
LOKIASV2_0141_ESMFold_hypothetical_protein	2py3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2py3-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome	0.117	267	183	34	241	12	278	2.509E-05	133
LOKIASV2_0141_ESMFold_hypothetical_protein	5amn-assembly1.cif.gz_A-2	LOKIASV2_0141_ESMFold_hypothetical_protein	5amn-assembly1.cif.gz_A-2 The Discovery of 2-Substituted Phenol Quinazolines as Potent and Selective RET Kinase Inhibitors	0.124	287	226	17	275	2	288	5.743E-06	133
LOKIASV2_0141_ESMFold_hypothetical_protein	3mes-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3mes-assembly1.cif.gz_B Crystal structure of choline kinase from Cryptosporidium parvum Iowa II, cgd3_2030	0.121	342	232	16	280	2	343	2.938E-05	133
LOKIASV2_0141_ESMFold_hypothetical_protein	2hw6-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2hw6-assembly1.cif.gz_A Crystal structure of Mnk1 catalytic domain	0.157	232	177	26	236	7	238	2.062E-04	132
LOKIASV2_0141_ESMFold_hypothetical_protein	4d55-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4d55-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain	0.122	251	219	28	278	9	258	3.265E-05	132
LOKIASV2_0141_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_A Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.128	224	166	28	218	10	233	7.992E-05	132
LOKIASV2_0141_ESMFold_hypothetical_protein	6yvy-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6yvy-assembly1.cif.gz_A FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide	0.125	255	221	28	280	10	264	9.224E-06	132
LOKIASV2_0141_ESMFold_hypothetical_protein	8c09-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8c09-assembly1.cif.gz_A Crystal structure of JAK2 JH2-I559F	0.146	266	205	34	274	6	271	1.562E-05	132
LOKIASV2_0141_ESMFold_hypothetical_protein	3lxl-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3lxl-assembly1.cif.gz_A Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6	0.128	229	160	34	218	7	235	4.720E-05	132
LOKIASV2_0141_ESMFold_hypothetical_protein	2x2m-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2x2m-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.141	284	222	20	278	3	286	8.302E-06	132
LOKIASV2_0141_ESMFold_hypothetical_protein	6glb-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6glb-assembly2.cif.gz_B Crystal structure of JAK3 in complex with Compound 20 (FM484)	0.116	236	171	34	227	8	243	3.441E-05	132
LOKIASV2_0141_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	0.137	282	217	28	279	20	301	1.562E-05	132
LOKIASV2_0141_ESMFold_hypothetical_protein	3kxx-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3kxx-assembly1.cif.gz_A Structure of the mutant Fibroblast Growth Factor receptor 1	0.137	285	192	28	251	17	301	3.265E-05	132
LOKIASV2_0141_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_C ASK1 kinase domain in complex with GS-4997	0.197	190	149	35	220	2	191	2.258E-05	131
LOKIASV2_0141_ESMFold_hypothetical_protein	2j0m-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2j0m-assembly1.cif.gz_B Crystal structure a two-chain complex between the FERM and kinase domains of focal adhesion kinase.	0.113	251	218	28	278	8	254	2.258E-05	131
LOKIASV2_0141_ESMFold_hypothetical_protein	3fzt-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3fzt-assembly1.cif.gz_A Crystal structure of PYK2 complexed with PF-4618433	0.143	255	218	26	280	3	257	7.876E-06	131
LOKIASV2_0141_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.143	215	171	35	234	2	216	6.474E-05	131
LOKIASV2_0141_ESMFold_hypothetical_protein	4tyi-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4tyi-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4	0.141	193	165	28	220	21	213	7.992E-05	131
LOKIASV2_0141_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_C The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.149	247	208	28	274	14	259	1.482E-05	131
LOKIASV2_0141_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_D The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.143	281	211	28	274	14	294	1.025E-05	131
LOKIASV2_0141_ESMFold_hypothetical_protein	3q6w-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3q6w-assembly1.cif.gz_A Structure of dually-phosphorylated MET receptor kinase in complex with an MK-2461 analog with specificity for the activated receptor	0.109	286	213	2	241	4	289	4.720E-05	131
LOKIASV2_0141_ESMFold_hypothetical_protein	3c5i-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3c5i-assembly1.cif.gz_A Crystal structure of Plasmodium knowlesi choline kinase, PKH_134520	0.120	329	240	11	284	11	339	2.938E-05	131
LOKIASV2_0141_ESMFold_hypothetical_protein	3mes-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3mes-assembly1.cif.gz_A Crystal structure of choline kinase from Cryptosporidium parvum Iowa II, cgd3_2030	0.115	340	236	16	283	2	341	3.265E-05	131
LOKIASV2_0141_ESMFold_hypothetical_protein	4bi1-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4bi1-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	0.135	243	190	29	271	10	230	2.032E-05	130
LOKIASV2_0141_ESMFold_hypothetical_protein	3tud-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3tud-assembly1.cif.gz_A Crystal structure of SYK kinase domain with N-(4-methyl-3-(8-methyl-7-oxo-2-(phenylamino)-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)-3-(trifluoromethyl)benzamide	0.127	247	193	28	274	7	228	1.265E-05	130
LOKIASV2_0141_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	0.150	267	209	28	274	14	280	1.265E-05	130
LOKIASV2_0141_ESMFold_hypothetical_protein	3kxx-assembly4.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	0.151	244	205	28	271	22	263	1.646E-05	130
LOKIASV2_0141_ESMFold_hypothetical_protein	2x2l-assembly1.cif.gz_A-2	LOKIASV2_0141_ESMFold_hypothetical_protein	2x2l-assembly1.cif.gz_A-2 Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.127	265	215	28	274	22	286	1.025E-05	130
LOKIASV2_0141_ESMFold_hypothetical_protein	7kie-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7kie-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 3	0.136	250	213	28	274	15	264	1.406E-05	130
LOKIASV2_0141_ESMFold_hypothetical_protein	5flf-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5flf-assembly1.cif.gz_A DISEASE LINKED MUTATION IN FGFR	0.128	254	212	28	271	18	271	1.829E-05	130
LOKIASV2_0141_ESMFold_hypothetical_protein	4riy-assembly2.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	4riy-assembly2.cif.gz_D Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-E909G mutation	0.113	264	217	28	273	24	287	1.928E-05	130
LOKIASV2_0141_ESMFold_hypothetical_protein	3ika-assembly3.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3ika-assembly3.cif.gz_A Crystal Structure of EGFR 696-1022 T790M Mutant Covalently Binding to WZ4002	0.127	264	214	28	273	16	279	2.032E-05	130
LOKIASV2_0141_ESMFold_hypothetical_protein	6yvy-assembly4.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	6yvy-assembly4.cif.gz_D FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide	0.133	253	214	28	280	7	254	2.747E-06	129
LOKIASV2_0141_ESMFold_hypothetical_protein	6tu9-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6tu9-assembly2.cif.gz_B The ROR1 Pseudokinase Domain Bound To Ponatinib	0.135	240	202	34	273	7	240	1.646E-05	129
LOKIASV2_0141_ESMFold_hypothetical_protein	3fzr-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3fzr-assembly1.cif.gz_A Crystal structure of PYK2 complexed with PF-431396	0.138	253	217	28	280	6	258	1.829E-05	129
LOKIASV2_0141_ESMFold_hypothetical_protein	6xjk-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6xjk-assembly1.cif.gz_A JAK2 JH2 in complex with JAK067	0.154	259	206	28	272	6	264	4.903E-06	129
LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly4.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly4.cif.gz_D Crystal structure of EphB1	0.113	256	223	31	282	4	259	1.139E-05	129
LOKIASV2_0141_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	0.120	260	220	28	278	9	268	2.142E-05	129
LOKIASV2_0141_ESMFold_hypothetical_protein	6nvl-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6nvl-assembly1.cif.gz_A FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	0.163	205	161	28	220	8	212	3.441E-05	129
LOKIASV2_0141_ESMFold_hypothetical_protein	7q7d-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7q7d-assembly1.cif.gz_A Room temperature structure of the human Serine/Threonine Kinase 17B (STK17B/DRAK2) in complex with ATP/ADP at 111 MPa helium gas pressure in a sapphire capillary	0.147	265	218	22	277	8	272	4.248E-05	129
LOKIASV2_0141_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	0.159	268	179	28	241	13	280	4.720E-05	129
LOKIASV2_0141_ESMFold_hypothetical_protein	4j99-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4j99-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.153	274	208	28	274	14	287	1.562E-05	129
LOKIASV2_0141_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_B Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.132	252	211	28	271	14	265	1.406E-05	129
LOKIASV2_0141_ESMFold_hypothetical_protein	6vnf-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6vnf-assembly1.cif.gz_B JAK2 JH1 in complex with MA9-086	0.124	280	210	34	274	7	286	2.509E-05	129
LOKIASV2_0141_ESMFold_hypothetical_protein	5ui0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ui0-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	0.129	281	219	28	279	20	300	1.646E-05	129
LOKIASV2_0141_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_B ASK1 kinase domain in complex with Compound 11	0.166	247	199	35	274	2	248	1.735E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly5.cif.gz_E	LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly5.cif.gz_E HER2 in complex with JBJ-08-178-01	0.129	250	209	34	274	10	259	1.735E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	8b8n-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8b8n-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Cdk2 inhibitor IV	0.149	270	208	30	274	4	273	1.482E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	7dua-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7dua-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with 4-amino-7-(1-methylcyclopropyl)-N-(5-methyl-1H-pyrazol-3-yl)pyrrolo[2,3-d]pyrimidine-5-carboxamide	0.141	253	214	28	277	21	273	2.258E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	3kn6-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3kn6-assembly1.cif.gz_A Crystal structure of the C-terminal kinase domain of MSK1	0.117	272	199	25	250	6	277	3.823E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	6agx-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6agx-assembly1.cif.gz_A The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.148	247	210	28	274	14	260	1.829E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	5usy-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5usy-assembly2.cif.gz_B JAK2 JH1 in complex with JNJ-7706621	0.115	277	212	34	274	8	284	4.030E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	4ork-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4ork-assembly2.cif.gz_B Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	0.112	295	237	9	276	1	295	6.824E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	3f5p-assembly17.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	3f5p-assembly17.cif.gz_D Complex Structure of Insulin-like Growth Factor Receptor and 3-Cyanoquinoline Inhibitor	0.138	265	176	34	238	18	282	4.720E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	4g5p-assembly3.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4g5p-assembly3.cif.gz_B Crystal structure of EGFR kinase T790M in complex with BIBW2992	0.131	253	183	28	239	15	267	5.827E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	2itu-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2itu-assembly1.cif.gz_A Crystal structure of EGFR kinase domain L858R mutation in complex with AFN941	0.112	255	218	28	274	16	270	1.406E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	3gqi-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3gqi-assembly1.cif.gz_A Crystal Structure of activated receptor tyrosine kinase in complex with substrates	0.147	260	210	28	274	14	273	2.258E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	7wu0-assembly1.cif.gz_v	LOKIASV2_0141_ESMFold_hypothetical_protein	7wu0-assembly1.cif.gz_v Cryo-EM structure of a human pre-40S ribosomal subunit - State RRP12-B3	0.126	247	198	12	238	69	315	8.879E-05	128
LOKIASV2_0141_ESMFold_hypothetical_protein	4c4e-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4c4e-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.125	236	197	36	271	10	235	2.032E-05	127
LOKIASV2_0141_ESMFold_hypothetical_protein	3gql-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	3gql-assembly3.cif.gz_C Crystal Structure of activated receptor tyrosine kinase in complex with substrates	0.137	254	184	28	241	15	268	3.265E-05	127
LOKIASV2_0141_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_D FGFR2 in complex with YJ001	0.138	260	212	28	274	14	273	2.788E-05	127
LOKIASV2_0141_ESMFold_hypothetical_protein	4un0-assembly2.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	4un0-assembly2.cif.gz_D Crystal structure of the human CDK12-cyclinK complex	0.136	197	162	28	215	4	200	5.528E-05	127
LOKIASV2_0141_ESMFold_hypothetical_protein	4ll0-assembly3.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4ll0-assembly3.cif.gz_B EGFR L858R/T790M in complex with PD168393	0.118	253	176	28	228	14	266	4.478E-05	127
LOKIASV2_0141_ESMFold_hypothetical_protein	3lj0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3lj0-assembly1.cif.gz_A IRE1 complexed with ADP and Quercetin	0.151	176	146	18	190	2	177	2.062E-04	127
LOKIASV2_0141_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_D-3	LOKIASV2_0141_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_D-3 ASK1 kinase domain in complex with Compound 11	0.171	206	159	35	227	2	207	6.142E-05	126
LOKIASV2_0141_ESMFold_hypothetical_protein	4gk2-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4gk2-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 66	0.129	247	211	28	274	12	254	2.032E-05	126
LOKIASV2_0141_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A Drosophila CaMKII-wt in complex with a fragment of the Eag potassium channel and Mg2+/AMPPN	0.117	214	166	28	216	7	220	9.865E-05	126
LOKIASV2_0141_ESMFold_hypothetical_protein	6fnh-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6fnh-assembly3.cif.gz_C Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712	0.151	205	171	32	236	10	212	3.097E-05	126
LOKIASV2_0141_ESMFold_hypothetical_protein	5mja-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5mja-assembly2.cif.gz_B Kinase domain of human EphB1 bound to a quinazoline-based inhibitor	0.124	258	215	28	274	10	267	9.224E-06	126
LOKIASV2_0141_ESMFold_hypothetical_protein	5flf-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5flf-assembly2.cif.gz_B DISEASE LINKED MUTATION IN FGFR	0.156	268	208	28	274	18	285	1.928E-05	126
LOKIASV2_0141_ESMFold_hypothetical_protein	3f5p-assembly17.cif.gz_K-2	LOKIASV2_0141_ESMFold_hypothetical_protein	3f5p-assembly17.cif.gz_K-2 Complex Structure of Insulin-like Growth Factor Receptor and 3-Cyanoquinoline Inhibitor	0.136	278	198	9	238	2	279	4.248E-05	126
LOKIASV2_0141_ESMFold_hypothetical_protein	5eg3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5eg3-assembly1.cif.gz_A Crystal Structure of the Activated FGF Receptor 2 (FGFR2) Kinase Domain in complex with the cSH2 domain of Phospholipase C gamma (PLCgamma)	0.147	284	218	28	284	15	298	3.097E-05	126
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap5-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ap5-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.119	236	193	36	271	11	230	2.380E-05	125
LOKIASV2_0141_ESMFold_hypothetical_protein	3fzs-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3fzs-assembly1.cif.gz_A Crystal Structure of PYK2 complexed with BIRB796	0.153	253	209	28	280	5	252	1.482E-05	125
LOKIASV2_0141_ESMFold_hypothetical_protein	4p5z-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4p5z-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with quinoxaline derivatives	0.119	255	217	28	282	12	258	3.441E-05	125
LOKIASV2_0141_ESMFold_hypothetical_protein	6nvi-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6nvi-assembly1.cif.gz_A FGFR4 complex with N-(3-chloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-5-fluorophenyl)acrylamide	0.131	256	216	28	277	14	269	1.200E-05	125
LOKIASV2_0141_ESMFold_hypothetical_protein	3gql-assembly4.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3gql-assembly4.cif.gz_B Crystal Structure of activated receptor tyrosine kinase in complex with substrates	0.141	250	178	28	235	15	264	6.824E-05	125
LOKIASV2_0141_ESMFold_hypothetical_protein	6ny4-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6ny4-assembly1.cif.gz_A Crystal structure of JAK3 kinase domain in complex with a pyrrolopyridazine carboxamide inhibitor	0.120	271	174	34	232	6	276	6.474E-05	125
LOKIASV2_0141_ESMFold_hypothetical_protein	5k72-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	5k72-assembly3.cif.gz_C IRAK4 in complex with Compound 21	0.159	248	197	40	274	31	278	5.827E-05	125
LOKIASV2_0141_ESMFold_hypothetical_protein	2psq-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2psq-assembly1.cif.gz_A Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain	0.125	274	219	28	278	13	286	2.938E-05	125
LOKIASV2_0141_ESMFold_hypothetical_protein	7vdp-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7vdp-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1	0.191	148	112	42	181	1	148	6.924E-04	125
LOKIASV2_0141_ESMFold_hypothetical_protein	4k33-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4k33-assembly1.cif.gz_A Crystal Structure of FGF Receptor 3 (FGFR3) Kinase Domain Harboring the K650E Mutation, a Gain-of-Function Mutation Responsible for Thanatophoric Dysplasia Type II and Spermatocytic Seminoma	0.149	277	209	28	274	13	289	2.032E-05	125
LOKIASV2_0141_ESMFold_hypothetical_protein	4kao-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4kao-assembly1.cif.gz_A FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-(4-pyridin-3- yl-phenyl)-urea	0.114	255	218	26	280	5	251	2.788E-05	124
LOKIASV2_0141_ESMFold_hypothetical_protein	4jt3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4jt3-assembly1.cif.gz_A Crystal Structure of TTK kinase domain with an inhibitor: 400740	0.125	206	171	29	234	11	206	8.879E-05	124
LOKIASV2_0141_ESMFold_hypothetical_protein	7mu7-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7mu7-assembly1.cif.gz_A Ask1 bound to compound 3	0.181	262	204	35	284	2	263	2.938E-05	124
LOKIASV2_0141_ESMFold_hypothetical_protein	6bss-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6bss-assembly1.cif.gz_A JAK2 JH2 in complex with NU6102	0.144	247	207	28	274	8	250	2.645E-05	124
LOKIASV2_0141_ESMFold_hypothetical_protein	3eqr-assembly3.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3eqr-assembly3.cif.gz_B Crystal Structure of Ack1 with compound T74	0.124	264	212	31	273	5	268	4.030E-05	124
LOKIASV2_0141_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_B FGFR2 in complex with YJ001	0.144	267	205	34	274	13	279	2.258E-05	124
LOKIASV2_0141_ESMFold_hypothetical_protein	5wal-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5wal-assembly1.cif.gz_A Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model	0.149	255	198	38	271	7	261	3.823E-05	124
LOKIASV2_0141_ESMFold_hypothetical_protein	6pnx-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6pnx-assembly1.cif.gz_B Crystal Structure of an Asymmetric Dimer of FGF Receptor 3 Kinases Trapped in A-loop Tyrosine Transphosphorylation Reaction	0.140	273	212	28	274	17	289	2.032E-05	124
LOKIASV2_0141_ESMFold_hypothetical_protein	2j0k-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2j0k-assembly1.cif.gz_A Crystal structure of a fragment of focal adhesion kinase containing the FERM and kinase domains.	0.105	248	186	28	236	348	595	1.503E-04	124
LOKIASV2_0141_ESMFold_hypothetical_protein	5ljj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ljj-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) in complex with Reversine	0.133	234	194	38	271	17	241	4.030E-05	123
LOKIASV2_0141_ESMFold_hypothetical_protein	5mjb-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5mjb-assembly2.cif.gz_B Kinase domain of human EphB1, G703C mutant, covalently bound to a quinazoline-based inhibitor	0.130	261	214	28	274	11	271	1.265E-05	123
LOKIASV2_0141_ESMFold_hypothetical_protein	4zjv-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4zjv-assembly1.cif.gz_A crystal structure of EGFR kinase domain in complex with Mitogen-inducible gene 6 protein	0.107	260	220	28	274	9	268	1.829E-05	123
LOKIASV2_0141_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_A Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	0.141	275	213	26	274	8	282	4.248E-05	123
LOKIASV2_0141_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	0.142	273	215	28	278	13	285	2.509E-05	123
LOKIASV2_0141_ESMFold_hypothetical_protein	3kn6-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3kn6-assembly2.cif.gz_B Crystal structure of the C-terminal kinase domain of MSK1	0.125	282	224	25	281	6	287	9.359E-05	123
LOKIASV2_0141_ESMFold_hypothetical_protein	3cly-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3cly-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domains Trapped in Trans-Phosphorylation Reaction	0.153	272	212	28	278	13	284	1.562E-05	123
LOKIASV2_0141_ESMFold_hypothetical_protein	1pkg-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	1pkg-assembly1.cif.gz_A Structure of a c-Kit Kinase Product Complex	0.133	273	209	32	273	19	291	4.975E-05	123
LOKIASV2_0141_ESMFold_hypothetical_protein	6jrx-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6jrx-assembly1.cif.gz_A EGFR T790M/C797S in complex with compound 6i	0.109	258	219	28	274	16	273	2.258E-05	123
LOKIASV2_0141_ESMFold_hypothetical_protein	5ui0-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5ui0-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	0.134	261	210	28	271	19	279	5.528E-05	123
LOKIASV2_0141_ESMFold_hypothetical_protein	2j0j-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2j0j-assembly1.cif.gz_A Crystal structure of a fragment of focal adhesion kinase containing the FERM and kinase domains.	0.127	253	218	28	278	356	608	6.380E-06	123
LOKIASV2_0141_ESMFold_hypothetical_protein	4p4c-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4p4c-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with quinoxaline derivatives	0.121	252	220	31	282	4	254	2.938E-05	122
LOKIASV2_0141_ESMFold_hypothetical_protein	7lg8-assembly4.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	7lg8-assembly4.cif.gz_D EGFR (T79M/V948R) in complex with naquotinib and an allosteric inhibitor	0.142	193	157	28	220	10	193	1.040E-04	122
LOKIASV2_0141_ESMFold_hypothetical_protein	7pcd-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7pcd-assembly1.cif.gz_A HER2 IN COMPLEX WITH A COVALENT INHIBITOR	0.122	252	211	34	274	9	260	1.829E-05	122
LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly1.cif.gz_B HER2 in complex with JBJ-08-178-01	0.133	251	213	28	274	13	263	3.265E-05	122
LOKIASV2_0141_ESMFold_hypothetical_protein	5i9u-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5i9u-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase	0.125	265	200	32	260	9	273	1.406E-05	122
LOKIASV2_0141_ESMFold_hypothetical_protein	2pzp-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2pzp-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible for Crouzon Syndrome	0.133	275	217	29	279	7	281	3.441E-05	122
LOKIASV2_0141_ESMFold_hypothetical_protein	4e1z-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4e1z-assembly1.cif.gz_A Structure of mouse Tyk-2 complexed to a 3-aminoindazole inhibitor	0.139	255	204	34	271	9	263	3.441E-05	122
LOKIASV2_0141_ESMFold_hypothetical_protein	2x2k-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2x2k-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.134	287	231	11	278	3	289	2.380E-05	122
LOKIASV2_0141_ESMFold_hypothetical_protein	7ju6-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7ju6-assembly1.cif.gz_B Structure of RET protein tyrosine kinase in complex with selpercatinib	0.118	267	220	28	277	24	290	2.938E-05	122
LOKIASV2_0141_ESMFold_hypothetical_protein	5ugx-assembly2.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ugx-assembly2.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	0.149	281	209	28	274	13	293	4.720E-05	122
LOKIASV2_0141_ESMFold_hypothetical_protein	3w2r-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3w2r-assembly1.cif.gz_A EGFR Kinase domain T790M/L858R mutant with compound 4	0.126	251	215	28	274	14	264	3.441E-05	122
LOKIASV2_0141_ESMFold_hypothetical_protein	1gag-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	1gag-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR	0.146	213	149	34	209	14	226	8.424E-05	122
LOKIASV2_0141_ESMFold_hypothetical_protein	4xlv-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4xlv-assembly1.cif.gz_A Crystal structure of the activated insulin receptor tyrosine kinase dimer	0.145	165	126	32	179	19	183	4.789E-04	122
LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly7.cif.gz_G	LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly7.cif.gz_G HER2 in complex with JBJ-08-178-01	0.134	251	213	28	274	14	264	4.248E-05	121
LOKIASV2_0141_ESMFold_hypothetical_protein	1pkg-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	1pkg-assembly2.cif.gz_B Structure of a c-Kit Kinase Product Complex	0.116	263	218	26	273	14	276	3.627E-05	121
LOKIASV2_0141_ESMFold_hypothetical_protein	6v9c-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6v9c-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with covalent inhibitor	0.133	265	217	28	278	14	278	1.334E-05	121
LOKIASV2_0141_ESMFold_hypothetical_protein	6p69-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6p69-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.	0.143	265	211	28	274	17	281	1.265E-05	121
LOKIASV2_0141_ESMFold_hypothetical_protein	7run-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7run-assembly1.cif.gz_A Crystal structure of phosphorylated RET tyrosine kinase domain complexed with a pyrrolo[2,3-d]pyrimidine inhibitor.	0.139	245	209	28	271	19	263	4.030E-05	121
LOKIASV2_0141_ESMFold_hypothetical_protein	6p8q-assembly2.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	6p8q-assembly2.cif.gz_D EGFR in complex with a dihydrodibenzodiazepinone allosteric inhibitor.	0.126	282	214	28	273	12	293	4.248E-05	121
LOKIASV2_0141_ESMFold_hypothetical_protein	2ito-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2ito-assembly1.cif.gz_A Crystal structure of EGFR kinase domain G719S mutation in complex with Iressa	0.107	252	220	28	274	16	267	2.645E-05	121
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqh-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8pqh-assembly1.cif.gz_A PDGFRA T674I mutant kinase domain in complex with avapritinib	0.129	300	244	3	283	14	313	4.975E-05	121
LOKIASV2_0141_ESMFold_hypothetical_protein	2jkq-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2jkq-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor	0.128	193	160	28	220	8	191	7.582E-05	120
LOKIASV2_0141_ESMFold_hypothetical_protein	4rwj-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4rwj-assembly2.cif.gz_B Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE)	0.151	258	209	28	274	19	276	2.258E-05	120
LOKIASV2_0141_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_A FGFR2 in complex with YJ001	0.152	267	209	28	274	14	280	2.258E-05	120
LOKIASV2_0141_ESMFold_hypothetical_protein	3nyx-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3nyx-assembly1.cif.gz_A Non-phosphorylated TYK2 JH1 domain with Quinoline-Thiadiazole-Thiophene Inhibitor	0.172	151	118	38	181	8	158	5.048E-04	120
LOKIASV2_0141_ESMFold_hypothetical_protein	6lvl-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6lvl-assembly1.cif.gz_A Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative	0.139	274	218	28	281	13	286	4.248E-05	120
LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly3.cif.gz_E	LOKIASV2_0141_ESMFold_hypothetical_protein	6hk6-assembly3.cif.gz_E Human RIOK2 bound to inhibitor	0.132	210	158	14	223	78	260	1.503E-04	120
LOKIASV2_0141_ESMFold_hypothetical_protein	3lcd-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3lcd-assembly1.cif.gz_A Inhibitor Bound to A DFG-In structure of the Kinase Domain of CSF-1R	0.148	266	209	28	273	24	289	4.975E-05	120
LOKIASV2_0141_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A Crystal Structure of PAK4 in complex with inhibitor CZH062	0.122	228	184	16	225	4	231	1.670E-04	120
LOKIASV2_0141_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	0.198	209	153	28	219	5	213	7.582E-05	120
LOKIASV2_0141_ESMFold_hypothetical_protein	4f9b-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	4f9b-assembly2.cif.gz_C Human CDC7 kinase in complex with DBF4 and PHA767491	0.132	277	229	12	276	5	281	4.720E-05	120
LOKIASV2_0141_ESMFold_hypothetical_protein	4y12-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4y12-assembly1.cif.gz_A Crystal structure of the S/T protein kinase PknG from Mycobacterium tuberculosis in complex with AGS	0.150	251	210	28	275	68	318	2.788E-05	120
LOKIASV2_0141_ESMFold_hypothetical_protein	4c4h-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4c4h-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.137	243	186	29	271	10	226	7.193E-05	119
LOKIASV2_0141_ESMFold_hypothetical_protein	4bi0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4bi0-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	0.130	236	193	36	271	10	232	4.248E-05	119
LOKIASV2_0141_ESMFold_hypothetical_protein	4gu9-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4gu9-assembly2.cif.gz_B Focal adhesion kinase catalytic domain in complex with (2-Fluoro-phenyl)-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amine	0.117	247	215	28	274	7	251	1.482E-05	119
LOKIASV2_0141_ESMFold_hypothetical_protein	3wyx-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3wyx-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 6-((3-(cyanomethoxy)-4-(1-methyl-1H-pyrazol-4-yl)phenyl)amino)-2-(cyclohexylamino)nicotinonitrile	0.141	236	193	36	271	10	235	3.097E-05	119
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap7-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ap7-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.136	236	194	36	271	17	241	3.265E-05	119
LOKIASV2_0141_ESMFold_hypothetical_protein	6nvg-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6nvg-assembly1.cif.gz_A FGFR4 complex with N-(3,5-dichloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)phenyl)acrylamide	0.127	257	217	28	277	14	270	6.142E-05	119
LOKIASV2_0141_ESMFold_hypothetical_protein	7ju6-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7ju6-assembly1.cif.gz_A Structure of RET protein tyrosine kinase in complex with selpercatinib	0.134	277	216	28	277	11	287	4.975E-05	119
LOKIASV2_0141_ESMFold_hypothetical_protein	4riy-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4riy-assembly1.cif.gz_B Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-E909G mutation	0.120	259	224	28	283	24	282	4.975E-05	119
LOKIASV2_0141_ESMFold_hypothetical_protein	4mq1-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	4mq1-assembly3.cif.gz_C The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.131	212	163	28	215	24	235	3.879E-04	119
LOKIASV2_0141_ESMFold_hypothetical_protein	2rio-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2rio-assembly1.cif.gz_A Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation of non-conventional splicing	0.159	196	163	28	223	8	202	2.415E-04	119
LOKIASV2_0141_ESMFold_hypothetical_protein	5nk8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5nk8-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2f	0.137	197	158	31	214	4	200	2.174E-04	118
LOKIASV2_0141_ESMFold_hypothetical_protein	4xey-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4xey-assembly1.cif.gz_A Crystal structure of an SH2-kinase domain construct of c-Abl tyrosine kinase	0.108	259	219	32	278	8	266	2.509E-05	118
LOKIASV2_0141_ESMFold_hypothetical_protein	5hvj-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5hvj-assembly2.cif.gz_B Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.104	255	226	28	282	9	261	5.244E-05	118
LOKIASV2_0141_ESMFold_hypothetical_protein	2py3-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2py3-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome	0.140	271	216	28	279	13	283	3.823E-05	118
LOKIASV2_0141_ESMFold_hypothetical_protein	6p68-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6p68-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.	0.140	262	212	28	274	16	277	3.265E-05	118
LOKIASV2_0141_ESMFold_hypothetical_protein	7wcl-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7wcl-assembly2.cif.gz_B Crystal structure of FGFR1 kinase domain with Pemigatinib	0.152	260	209	28	274	22	281	2.645E-05	118
LOKIASV2_0141_ESMFold_hypothetical_protein	6jx0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6jx0-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 T790M in complex with AZD9291 prepared by co-crystallization	0.123	264	218	34	283	10	273	3.097E-05	118
LOKIASV2_0141_ESMFold_hypothetical_protein	7jxi-assembly2.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7jxi-assembly2.cif.gz_A EGFR kinase (T790M/V948R) in complex with PF-06747775	0.150	200	156	28	227	12	196	1.096E-04	118
LOKIASV2_0141_ESMFold_hypothetical_protein	1k3a-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	1k3a-assembly1.cif.gz_A Structure of the Insulin-like Growth Factor 1 Receptor Kinase	0.129	225	179	28	234	4	228	1.040E-04	118
LOKIASV2_0141_ESMFold_hypothetical_protein	4gu9-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4gu9-assembly1.cif.gz_A Focal adhesion kinase catalytic domain in complex with (2-Fluoro-phenyl)-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amine	0.119	251	213	28	278	8	250	2.258E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	3tub-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3tub-assembly1.cif.gz_A Crystal structure of SYK kinase domain with 1-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-3-((1R,2S)-2-phenylcyclopropyl)urea	0.124	247	193	28	274	8	228	1.406E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	2jkm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2jkm-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor	0.145	251	212	28	278	9	257	1.406E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	5mrb-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5mrb-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) in complex with Cpd-5	0.131	243	199	29	271	12	241	5.827E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	5zwj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5zwj-assembly1.cif.gz_A Crystal structure of EGFR 675-1022 T790M/C797S/V948R in complex with EAI045	0.124	247	213	28	274	10	253	3.823E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and GluN2B in complex with ADP	0.113	259	222	26	284	4	254	2.174E-04	117
LOKIASV2_0141_ESMFold_hypothetical_protein	3cc6-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3cc6-assembly1.cif.gz_A Crystal structure of kinase domain of protein tyrosine kinase 2 beta (PTK2B)	0.132	256	219	28	280	10	265	2.509E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly2.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7jxh-assembly2.cif.gz_A HER2 in complex with JBJ-08-178-01	0.137	253	206	34	273	13	265	4.248E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	3tt0-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3tt0-assembly2.cif.gz_B Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)	0.127	244	198	28	271	19	246	2.788E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	8a2d-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8a2d-assembly1.cif.gz_A EGFR kinase domain (L858R/V948R) in complex with 2-[4-(difluoromethyl)-6-[2-[4-[[4-(hydroxymethyl)-1-piperidyl]methyl]phenyl]ethynyl]-7-methyl-indazol-2-yl]-2-spiro[6,7-dihydropyrrolo[1,2-c]imidazole-5,1'-cyclopropane]-1-yl-N-thiazol-2-yl-acetamide	0.146	195	161	31	220	7	201	7.582E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	7a6i-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7a6i-assembly1.cif.gz_A Crystal Structure of EGFR-T790M/V948R in Complex with LDC8201	0.116	261	217	28	274	9	269	5.244E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	5ugx-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5ugx-assembly1.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	0.141	266	211	28	274	13	278	6.142E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.107	273	223	28	278	10	282	1.426E-04	117
LOKIASV2_0141_ESMFold_hypothetical_protein	6gla-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6gla-assembly2.cif.gz_B Crystal structure of JAK3 in complex with Compound 11 (FM481)	0.132	254	206	34	271	8	261	2.509E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	5a46-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5a46-assembly1.cif.gz_A FGFR1 in complex with dovitinib	0.144	247	211	28	274	14	260	4.478E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	7ozb-assembly2.cif.gz_BBB	LOKIASV2_0141_ESMFold_hypothetical_protein	7ozb-assembly2.cif.gz_BBB FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 38.	0.160	244	202	28	269	18	261	4.248E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	6joi-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6joi-assembly1.cif.gz_A Crystal structure of PDGFRA T674I in complex with crenolanib by co-crystallization	0.144	196	163	28	223	24	214	4.543E-04	117
LOKIASV2_0141_ESMFold_hypothetical_protein	4j98-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4j98-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659Q Mutation.	0.148	281	210	28	274	20	300	4.720E-05	117
LOKIASV2_0141_ESMFold_hypothetical_protein	6ilz-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6ilz-assembly2.cif.gz_C Crystal structure of PKCiota in complex with inhibitor	0.147	182	152	35	213	2	183	1.761E-04	117
LOKIASV2_0141_ESMFold_hypothetical_protein	4js8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4js8-assembly1.cif.gz_A Crystal structure of TTK kinase domain with an inhibitor: 401348	0.143	236	196	36	271	11	240	2.380E-05	116
LOKIASV2_0141_ESMFold_hypothetical_protein	4h1j-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4h1j-assembly1.cif.gz_A Crystal structure of PYK2 with the pyrazole 13a	0.115	256	223	28	280	6	261	4.030E-05	116
LOKIASV2_0141_ESMFold_hypothetical_protein	7vjl-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7vjl-assembly2.cif.gz_B The crystal structure of FGFR4 kinase domain in complex with N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-(2,2,2-trifluoroacetyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide	0.135	253	217	28	280	14	265	2.938E-05	116
LOKIASV2_0141_ESMFold_hypothetical_protein	6bl8-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6bl8-assembly2.cif.gz_B Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	0.120	256	214	32	275	6	261	6.824E-05	116
LOKIASV2_0141_ESMFold_hypothetical_protein	2pz5-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2pz5-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549T Mutation Responsible for Pfeiffer Syndrome	0.139	273	215	29	279	7	279	6.142E-05	116
LOKIASV2_0141_ESMFold_hypothetical_protein	5ew8-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5ew8-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693	0.140	246	209	28	271	17	262	3.823E-05	116
LOKIASV2_0141_ESMFold_hypothetical_protein	5nkg-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5nkg-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 3d	0.144	200	139	31	193	4	203	1.670E-04	116
LOKIASV2_0141_ESMFold_hypothetical_protein	8e1x-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	8e1x-assembly1.cif.gz_B FGFR2 kinase domain in complex with a Pyrazolo[1,5-a]pyrimidine analog (Compound 29)	0.147	217	165	26	220	12	228	1.670E-04	116
LOKIASV2_0141_ESMFold_hypothetical_protein	7v29-assembly2.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7v29-assembly2.cif.gz_A Crystal structure of FGFR4 with a dual-warhead covalent inhhibitor	0.134	280	216	28	277	13	292	2.645E-05	116
LOKIASV2_0141_ESMFold_hypothetical_protein	1t46-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	1t46-assembly1.cif.gz_A STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE	0.144	271	210	28	273	24	294	4.975E-05	116
LOKIASV2_0141_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	0.144	286	215	28	279	19	304	1.096E-04	116
LOKIASV2_0141_ESMFold_hypothetical_protein	3oz6-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3oz6-assembly1.cif.gz_A Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	0.131	275	211	28	271	7	281	1.585E-04	116
LOKIASV2_0141_ESMFold_hypothetical_protein	4bhz-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4bhz-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	0.136	236	189	36	271	10	229	5.528E-05	115
LOKIASV2_0141_ESMFold_hypothetical_protein	4cv8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4cv8-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	0.132	243	194	29	271	10	233	1.218E-04	115
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap2-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ap2-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.142	192	154	38	218	16	207	1.585E-04	115
LOKIASV2_0141_ESMFold_hypothetical_protein	5flf-assembly5.cif.gz_E	LOKIASV2_0141_ESMFold_hypothetical_protein	5flf-assembly5.cif.gz_E DISEASE LINKED MUTATION IN FGFR	0.147	249	179	29	239	6	254	1.096E-04	115
LOKIASV2_0141_ESMFold_hypothetical_protein	5uq0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5uq0-assembly1.cif.gz_A FGFR1 kinase domain complex with fragment 2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxamide	0.157	242	186	28	269	14	235	6.142E-05	115
LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly1.cif.gz_A Crystal structure of EphB1	0.123	242	208	45	282	20	261	4.975E-05	115
LOKIASV2_0141_ESMFold_hypothetical_protein	8c0a-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	8c0a-assembly2.cif.gz_B Crystal structure of JAK2 JH2-R683S	0.140	264	211	28	273	9	272	2.938E-05	115
LOKIASV2_0141_ESMFold_hypothetical_protein	4ymj-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4ymj-assembly2.cif.gz_B (R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK Inhibitors	0.128	241	208	34	274	10	248	5.827E-05	115
LOKIASV2_0141_ESMFold_hypothetical_protein	4rmz-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4rmz-assembly1.cif.gz_A Crystal Structure of IRAK-4	0.144	277	224	12	274	10	286	6.142E-05	115
LOKIASV2_0141_ESMFold_hypothetical_protein	5lwm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5lwm-assembly1.cif.gz_A Crystal structure of JAK3 in complex with Compound 4 (FM381)	0.151	259	201	34	271	7	265	8.424E-05	115
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqc-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	8pqc-assembly2.cif.gz_B c-KIT kinase domain in complex with avapritinib derivative 9	0.110	272	222	28	277	23	294	9.359E-05	115
LOKIASV2_0141_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10-ATP-gamma-S Complex	0.168	211	159	28	219	5	215	1.040E-04	115
LOKIASV2_0141_ESMFold_hypothetical_protein	2iwi-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2iwi-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN PIM2 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1	0.125	151	125	31	181	3	146	5.399E-03	114
LOKIASV2_0141_ESMFold_hypothetical_protein	2og8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2og8-assembly1.cif.gz_A crystal structure of aminoquinazoline 36 bound to Lck	0.139	244	186	28	271	8	224	6.142E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	6yvs-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6yvs-assembly3.cif.gz_C FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 5-{4-[(Pyridin-3-ylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one	0.140	253	211	28	280	8	253	2.142E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly2.cif.gz_B Crystal structure of EphB1	0.128	251	213	32	282	5	249	7.193E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	4h1m-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4h1m-assembly1.cif.gz_A Crystal structure of PYK2 with the indole 10c	0.155	253	210	28	280	5	254	5.827E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	3dbq-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3dbq-assembly1.cif.gz_A Crystal structure of TTK kinase domain	0.144	241	189	29	269	11	232	5.528E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	2fb8-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2fb8-assembly2.cif.gz_B Structure of the B-Raf kinase domain bound to SB-590885	0.137	205	166	28	220	8	212	2.062E-04	114
LOKIASV2_0141_ESMFold_hypothetical_protein	4d58-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4d58-assembly2.cif.gz_B Focal Adhesion Kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor	0.135	251	216	28	278	8	258	3.441E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	5wnm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5wnm-assembly1.cif.gz_A Crystal structure of murine receptor-interacting protein 4 (Ripk4) D143N bound to tozasertib (VX-680)	0.135	248	210	31	274	13	260	2.981E-04	114
LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly9.cif.gz_I	LOKIASV2_0141_ESMFold_hypothetical_protein	3zfx-assembly9.cif.gz_I Crystal structure of EphB1	0.119	255	221	28	282	8	259	9.359E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	4ymj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4ymj-assembly1.cif.gz_A (R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK Inhibitors	0.145	247	201	28	274	11	246	1.218E-04	114
LOKIASV2_0141_ESMFold_hypothetical_protein	4twn-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4twn-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with Birb796	0.133	257	218	31	282	9	265	5.528E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	5ntt-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ntt-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) C604Y mutant in complex with NMS-P715	0.121	243	208	29	271	15	252	8.424E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.137	254	204	35	271	2	255	1.155E-04	114
LOKIASV2_0141_ESMFold_hypothetical_protein	4tyj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4tyj-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	0.128	262	220	28	280	16	277	4.975E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	3qqu-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3qqu-assembly1.cif.gz_A Cocrystal structure of unphosphorylated igf with pyrimidine 8	0.124	219	177	32	234	5	223	4.248E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	4uxq-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4uxq-assembly1.cif.gz_A FGFR4 in complex with Ponatinib	0.131	271	216	28	277	15	285	2.509E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	5t1t-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	5t1t-assembly3.cif.gz_C Irak4 kinase - compound 1 co-structure	0.139	252	195	48	274	35	286	4.248E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	4v04-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4v04-assembly2.cif.gz_B FGFR1 in complex with ponatinib.	0.148	247	204	28	274	20	260	4.248E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	3b8q-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3b8q-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with a naphthamide inhibitor	0.140	271	219	28	283	16	286	7.193E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqg-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	8pqg-assembly2.cif.gz_C c-KIT T670I mutated kinase domain in complex with avapritinib	0.122	276	219	28	277	24	299	7.992E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	2zm3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2zm3-assembly1.cif.gz_A Complex Structure of Insulin-like Growth Factor Receptor and Isoquinolinedione Inhibitor	0.136	269	176	34	238	18	286	7.992E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	3tt0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3tt0-assembly1.cif.gz_A Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)	0.143	260	211	28	274	17	276	5.244E-05	114
LOKIASV2_0141_ESMFold_hypothetical_protein	3zzw-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3zzw-assembly1.cif.gz_B Crystal structure of the kinase domain of ROR2	0.120	257	216	28	273	7	263	5.827E-05	113
LOKIASV2_0141_ESMFold_hypothetical_protein	8bof-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8bof-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 12	0.140	194	157	32	214	5	198	3.492E-04	113
LOKIASV2_0141_ESMFold_hypothetical_protein	4f1t-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4f1t-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain from D. discoideum bound to the ROCK Inhibitor H1152	0.121	152	127	36	180	10	161	2.205E-03	113
LOKIASV2_0141_ESMFold_hypothetical_protein	5vam-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5vam-assembly1.cif.gz_A BRAF in Complex with RAF709	0.131	261	216	28	277	8	268	5.244E-05	113
LOKIASV2_0141_ESMFold_hypothetical_protein	2vx0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2vx0-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.140	262	218	28	282	7	268	9.865E-05	113
LOKIASV2_0141_ESMFold_hypothetical_protein	5am6-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5am6-assembly2.cif.gz_B Native FGFR1 with an inhibitor	0.159	242	195	28	269	20	252	9.865E-05	113
LOKIASV2_0141_ESMFold_hypothetical_protein	8atb-assembly1.cif.gz_AAA	LOKIASV2_0141_ESMFold_hypothetical_protein	8atb-assembly1.cif.gz_AAA Discovery of IRAK4 Inhibitor 16	0.149	256	202	38	275	24	279	1.040E-04	113
LOKIASV2_0141_ESMFold_hypothetical_protein	6kzc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6kzc-assembly1.cif.gz_A crystal structure of TRKc in complex with 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-2-methyl-N-(3-((4- methylpiperazin-1-yl)methyl)-5- (trifluoromethyl)phenyl)benzamide	0.151	204	170	28	228	10	213	3.680E-04	113
LOKIASV2_0141_ESMFold_hypothetical_protein	5o4a-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5o4a-assembly1.cif.gz_A Human FGF in complex with a covalent inhibitor	0.144	210	164	28	220	14	223	2.828E-04	113
LOKIASV2_0141_ESMFold_hypothetical_protein	7v29-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7v29-assembly1.cif.gz_B Crystal structure of FGFR4 with a dual-warhead covalent inhhibitor	0.139	277	214	28	277	13	289	4.248E-05	113
LOKIASV2_0141_ESMFold_hypothetical_protein	3lvp-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	3lvp-assembly3.cif.gz_C Crystal structure of bisphosphorylated IGF1-R Kinase domain (2P) in complex with a bis-azaindole inhibitor	0.139	270	180	29	238	6	275	1.956E-04	113
LOKIASV2_0141_ESMFold_hypothetical_protein	7ukz-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	7ukz-assembly3.cif.gz_C CDK11 in complex with small molecule inhibitor OTS964	0.124	191	165	35	223	4	194	5.609E-04	113
LOKIASV2_0141_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A Crystal structure of PAK1 in complex with an inhibitor compound 5	0.129	272	222	17	272	2	273	8.879E-05	113
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqd-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8pqd-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib derivative 10	0.110	274	222	28	277	23	296	7.193E-05	113
LOKIASV2_0141_ESMFold_hypothetical_protein	7f3m-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7f3m-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain with PRN1371	0.132	281	216	28	277	14	294	4.030E-05	113
LOKIASV2_0141_ESMFold_hypothetical_protein	6v6a-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6v6a-assembly2.cif.gz_C Inhibitory scaffolding of the ancient MAPK, ERK7	0.130	262	170	34	229	7	268	1.040E-04	113
LOKIASV2_0141_ESMFold_hypothetical_protein	7ybx-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7ybx-assembly1.cif.gz_A Crystal structure of FGFR4(V550M) kinase domain with 10z	0.135	284	215	28	277	14	297	4.478E-05	113
LOKIASV2_0141_ESMFold_hypothetical_protein	5ehl-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ehl-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.135	243	193	29	271	11	234	9.359E-05	112
LOKIASV2_0141_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A Drosophila CaMKII-D136N in complex with a phosphorylated fragment of the Eag potassium channel and Mg2+/ADP	0.095	257	219	28	270	7	263	2.174E-04	112
LOKIASV2_0141_ESMFold_hypothetical_protein	6tfu-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6tfu-assembly1.cif.gz_A Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 14d	0.138	256	212	28	283	12	258	5.827E-05	112
LOKIASV2_0141_ESMFold_hypothetical_protein	6ziw-assembly1.cif.gz_I	LOKIASV2_0141_ESMFold_hypothetical_protein	6ziw-assembly1.cif.gz_I The IRAK3 Pseudokinase Domain Bound To ATPgammaS	0.137	249	207	37	277	17	265	1.353E-04	112
LOKIASV2_0141_ESMFold_hypothetical_protein	6tg1-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6tg1-assembly1.cif.gz_A Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 21b	0.125	249	211	31	272	9	257	6.824E-05	112
LOKIASV2_0141_ESMFold_hypothetical_protein	6yi8-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6yi8-assembly2.cif.gz_B HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB	0.133	253	217	28	278	16	268	7.992E-05	112
LOKIASV2_0141_ESMFold_hypothetical_protein	5nud-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5nud-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	0.133	252	216	28	277	19	270	9.359E-05	112
LOKIASV2_0141_ESMFold_hypothetical_protein	5gnk-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5gnk-assembly1.cif.gz_A Crystal structure of EGFR 696-988 T790M in complex with LXX-6-34	0.119	253	214	31	274	11	263	3.627E-05	112
LOKIASV2_0141_ESMFold_hypothetical_protein	6yi8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6yi8-assembly1.cif.gz_A HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB	0.134	260	216	28	277	14	273	6.142E-05	112
LOKIASV2_0141_ESMFold_hypothetical_protein	7ozd-assembly2.cif.gz_BBB	LOKIASV2_0141_ESMFold_hypothetical_protein	7ozd-assembly2.cif.gz_BBB FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 34.	0.135	262	213	28	274	18	279	6.824E-05	112
LOKIASV2_0141_ESMFold_hypothetical_protein	6p68-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6p68-assembly3.cif.gz_C Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.	0.152	261	217	28	284	8	268	6.474E-05	112
LOKIASV2_0141_ESMFold_hypothetical_protein	4nka-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4nka-assembly1.cif.gz_B Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 2	0.143	244	205	28	271	20	259	4.720E-05	112
LOKIASV2_0141_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A Pak1 in complex with bis-anilino pyrimidine inhibitor	0.130	254	212	28	272	16	269	2.546E-04	112
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqg-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8pqg-assembly1.cif.gz_A c-KIT T670I mutated kinase domain in complex with avapritinib	0.114	265	217	28	273	23	287	1.155E-04	112
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqi-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8pqi-assembly1.cif.gz_A PDGFRA T674I mutant kinase domain in complex with avapritinib derivative 9	0.150	268	217	28	283	26	293	1.155E-04	112
LOKIASV2_0141_ESMFold_hypothetical_protein	6wa2-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6wa2-assembly2.cif.gz_C Crystal structure of EGFR(T790M/V948R) in complex with LN3753	0.141	191	162	31	220	7	197	1.096E-04	112
LOKIASV2_0141_ESMFold_hypothetical_protein	4fk3-assembly2.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4fk3-assembly2.cif.gz_A B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203	0.115	246	212	28	273	9	249	9.359E-05	111
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ap3-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.132	236	193	36	271	10	232	7.582E-05	111
LOKIASV2_0141_ESMFold_hypothetical_protein	5na0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5na0-assembly1.cif.gz_A TTK kinase domain in complex with a PEG-linked pyrimido-indolizine	0.142	192	152	29	220	10	187	3.879E-04	111
LOKIASV2_0141_ESMFold_hypothetical_protein	6yxv-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6yxv-assembly2.cif.gz_B FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-Methyl-N-{3-[(2-phenylamino-5-trifluoromethyl-pyrimidin-4-ylamino)-methyl]-pyridin-2-yl}-methanesulfonamide	0.126	252	219	26	277	5	256	4.720E-05	111
LOKIASV2_0141_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity	0.141	247	204	28	274	7	244	1.218E-04	111
LOKIASV2_0141_ESMFold_hypothetical_protein	7aw4-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7aw4-assembly1.cif.gz_A MerTK kinase domain with type 3 inhibitor from a DNA-encoded library	0.138	252	215	28	277	11	262	9.359E-05	111
LOKIASV2_0141_ESMFold_hypothetical_protein	1vr2-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	1vr2-assembly1.cif.gz_A HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN	0.151	261	209	28	274	14	274	9.865E-05	111
LOKIASV2_0141_ESMFold_hypothetical_protein	3kk9-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3kk9-assembly1.cif.gz_A CaMKII Substrate Complex B	0.113	196	172	28	222	6	201	5.912E-04	111
LOKIASV2_0141_ESMFold_hypothetical_protein	8stg-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8stg-assembly1.cif.gz_A Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations	0.145	244	198	26	269	18	250	6.142E-05	111
LOKIASV2_0141_ESMFold_hypothetical_protein	4uwc-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4uwc-assembly2.cif.gz_B Fibroblast growth factor receptor 1 kinase in complex with JK-P3	0.132	256	211	28	271	19	274	8.424E-05	111
LOKIASV2_0141_ESMFold_hypothetical_protein	5cav-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5cav-assembly1.cif.gz_A EGFR kinase domain with compound 41a	0.111	262	213	34	274	14	275	4.975E-05	111
LOKIASV2_0141_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B Crystal structure of the kinase MARK3/Par-1: T211A-S215A double mutant	0.132	148	124	28	175	6	149	1.055E-03	111
LOKIASV2_0141_ESMFold_hypothetical_protein	2rio-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2rio-assembly1.cif.gz_B Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation of non-conventional splicing	0.162	196	162	28	223	8	201	4.789E-04	111
LOKIASV2_0141_ESMFold_hypothetical_protein	4c4g-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4c4g-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.130	236	191	36	271	11	230	6.824E-05	110
LOKIASV2_0141_ESMFold_hypothetical_protein	7kpl-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7kpl-assembly1.cif.gz_A Crystal structure of hEphB1 in apo form	0.109	255	220	28	282	8	255	1.761E-04	110
LOKIASV2_0141_ESMFold_hypothetical_protein	4k8a-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4k8a-assembly2.cif.gz_B Fragment-based discovery of Focal Adhesion Kinase Inhibitors	0.125	250	217	28	277	8	256	3.627E-05	110
LOKIASV2_0141_ESMFold_hypothetical_protein	6tnc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6tnc-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 46	0.143	211	171	35	234	1	211	6.474E-05	110
LOKIASV2_0141_ESMFold_hypothetical_protein	3lzb-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3lzb-assembly2.cif.gz_B EGFR kinase domain complexed with an imidazo[2,1-b]thiazole inhibitor	0.126	256	215	28	283	9	255	1.585E-04	110
LOKIASV2_0141_ESMFold_hypothetical_protein	6c1c-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6c1c-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37116	0.146	247	192	28	274	15	240	1.096E-04	110
LOKIASV2_0141_ESMFold_hypothetical_protein	5nud-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5nud-assembly1.cif.gz_A FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	0.126	253	220	28	280	14	266	1.218E-04	110
LOKIASV2_0141_ESMFold_hypothetical_protein	6rbd-assembly1.cif.gz_l	LOKIASV2_0141_ESMFold_hypothetical_protein	6rbd-assembly1.cif.gz_l State 1 of yeast Tsr1-TAP Rps20-Deltaloop pre-40S particles	0.121	224	163	15	238	68	254	5.048E-04	110
LOKIASV2_0141_ESMFold_hypothetical_protein	3ky2-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3ky2-assembly2.cif.gz_B Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domain	0.151	244	200	28	271	18	254	7.582E-05	110
LOKIASV2_0141_ESMFold_hypothetical_protein	2xik-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2xik-assembly1.cif.gz_A Structure of Human YSK1 (Yeast Sps1-Ste20-related Kinase 1)	0.133	270	212	28	273	17	286	1.096E-04	110
LOKIASV2_0141_ESMFold_hypothetical_protein	5vnd-assembly3.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5vnd-assembly3.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527	0.158	247	203	28	269	18	264	9.359E-05	110
LOKIASV2_0141_ESMFold_hypothetical_protein	7yc3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7yc3-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain with 10t	0.124	284	218	28	277	14	297	7.193E-05	110
LOKIASV2_0141_ESMFold_hypothetical_protein	5x2c-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5x2c-assembly2.cif.gz_B Crystal structure of EGFR 696-1022 T790M/V948R in complex with SKLB(5)	0.121	251	216	28	278	11	257	8.879E-05	110
LOKIASV2_0141_ESMFold_hypothetical_protein	5cnn-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5cnn-assembly2.cif.gz_B Crystal structure of the EGFR kinase domain mutant I682Q	0.138	251	212	28	278	12	258	9.865E-05	110
LOKIASV2_0141_ESMFold_hypothetical_protein	5ehy-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ehy-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.135	236	192	36	271	11	233	1.155E-04	109
LOKIASV2_0141_ESMFold_hypothetical_protein	3cek-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3cek-assembly1.cif.gz_A Crystal structure of human dual specificity protein kinase (TTK)	0.135	236	193	36	271	11	234	8.879E-05	109
LOKIASV2_0141_ESMFold_hypothetical_protein	5n87-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5n87-assembly1.cif.gz_A TTK kinase domain in complex with NTRC 0066-0	0.132	243	194	29	271	10	234	1.284E-04	109
LOKIASV2_0141_ESMFold_hypothetical_protein	3sxr-assembly3.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3sxr-assembly3.cif.gz_A Crystal structure of BMX non-receptor tyrosine kinase complex with dasatinib	0.106	254	217	31	274	5	258	7.193E-05	109
LOKIASV2_0141_ESMFold_hypothetical_protein	3h9f-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3h9f-assembly1.cif.gz_A Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrimido-diazepin ligand	0.137	236	198	36	271	11	241	1.218E-04	109
LOKIASV2_0141_ESMFold_hypothetical_protein	7kx8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7kx8-assembly1.cif.gz_A Crystal structure of DCLK1-Cter in complex with FMF-03-055-1	0.134	213	159	14	226	4	188	2.415E-04	109
LOKIASV2_0141_ESMFold_hypothetical_protein	7pi4-assembly1.cif.gz_DDD	LOKIASV2_0141_ESMFold_hypothetical_protein	7pi4-assembly1.cif.gz_DDD FAK Protac GSK215 in complex with FAK and pVHL:ElonginC:ElonginB	0.133	253	216	28	277	7	259	4.720E-05	109
LOKIASV2_0141_ESMFold_hypothetical_protein	5jkg-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5jkg-assembly1.cif.gz_A The crystal structure of FGFR4 kinase domain in complex with LY2874455	0.140	193	162	28	220	14	202	4.543E-04	109
LOKIASV2_0141_ESMFold_hypothetical_protein	4ks8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4ks8-assembly1.cif.gz_A PAK6 kinase domain in complex with sunitinib	0.108	229	185	9	216	1	229	5.321E-04	109
LOKIASV2_0141_ESMFold_hypothetical_protein	4tyg-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4tyg-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	0.137	269	215	28	277	23	291	6.142E-05	109
LOKIASV2_0141_ESMFold_hypothetical_protein	2v7o-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2v7o-assembly1.cif.gz_A Crystal structure of human calcium-calmodulin-dependent protein kinase II gamma	0.106	286	204	28	256	18	303	2.062E-04	109
LOKIASV2_0141_ESMFold_hypothetical_protein	7wcl-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7wcl-assembly1.cif.gz_A Crystal structure of FGFR1 kinase domain with Pemigatinib	0.131	281	183	28	239	19	299	3.492E-04	109
LOKIASV2_0141_ESMFold_hypothetical_protein	6yvs-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6yvs-assembly2.cif.gz_B FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 5-{4-[(Pyridin-3-ylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one	0.128	250	212	28	277	7	250	4.030E-05	108
LOKIASV2_0141_ESMFold_hypothetical_protein	4cv9-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4cv9-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	0.126	233	188	39	271	18	233	1.353E-04	108
LOKIASV2_0141_ESMFold_hypothetical_protein	3vqu-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3vqu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-amino-5-cyano-6-ethoxypyridin-2- yl)amino]benzamide	0.160	236	189	36	271	10	235	1.284E-04	108
LOKIASV2_0141_ESMFold_hypothetical_protein	6b4w-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6b4w-assembly1.cif.gz_A TTK in Complex with Inhibitor	0.145	236	194	36	271	11	238	9.359E-05	108
LOKIASV2_0141_ESMFold_hypothetical_protein	3uqf-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3uqf-assembly1.cif.gz_A c-SRC kinase domain in complex with BKI RM-1-89	0.138	257	213	28	284	9	256	1.218E-04	108
LOKIASV2_0141_ESMFold_hypothetical_protein	5vam-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5vam-assembly2.cif.gz_B BRAF in Complex with RAF709	0.133	252	216	28	277	8	259	1.856E-04	108
LOKIASV2_0141_ESMFold_hypothetical_protein	6c1o-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6c1o-assembly2.cif.gz_B FGFR1 kinase domain complexed with FIIN-1	0.148	249	179	29	239	8	256	2.291E-04	108
LOKIASV2_0141_ESMFold_hypothetical_protein	5wnj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5wnj-assembly1.cif.gz_A Crystal structure of murine receptor-interacting protein kinase 4 (Ripk4) D143N in complex with lestaurtinib	0.131	249	211	31	274	13	261	5.912E-04	108
LOKIASV2_0141_ESMFold_hypothetical_protein	7lqd-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7lqd-assembly1.cif.gz_A Structure of Human MPS1 (TTK) covalently bound to RMS-07 inhibitor	0.131	235	201	37	271	15	246	1.761E-04	108
LOKIASV2_0141_ESMFold_hypothetical_protein	5xff-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5xff-assembly1.cif.gz_A Crystal structure of LY2874455 in complex of FGFR4 gatekeeper mutation (V550L)	0.127	255	217	28	277	14	268	1.856E-04	108
LOKIASV2_0141_ESMFold_hypothetical_protein	5nka-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5nka-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2g	0.134	255	217	31	282	4	258	4.478E-05	108
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap1-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ap1-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.134	239	204	36	271	11	249	5.528E-05	108
LOKIASV2_0141_ESMFold_hypothetical_protein	8b9e-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8b9e-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Z902-A3	0.162	245	201	34	274	8	252	5.244E-05	108
LOKIASV2_0141_ESMFold_hypothetical_protein	5fdx-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5fdx-assembly1.cif.gz_A Structure of DDR1 receptor tyrosine kinase in complex with D2164 inhibitor at 2.65 Angstroms resolution.	0.135	273	212	28	273	6	278	7.193E-05	108
LOKIASV2_0141_ESMFold_hypothetical_protein	4rwi-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4rwi-assembly2.cif.gz_B Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M), apo	0.131	258	214	28	274	17	274	9.359E-05	108
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqe-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	8pqe-assembly2.cif.gz_B c-KIT kinase domain in complex with avapritinib derivative 11	0.109	257	218	28	273	23	279	2.174E-04	108
LOKIASV2_0141_ESMFold_hypothetical_protein	6sdc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6sdc-assembly1.cif.gz_A Crystal structure of D1228V cMET bound by foretinib	0.102	220	197	1	220	1	220	5.609E-04	108
LOKIASV2_0141_ESMFold_hypothetical_protein	7q52-assembly1.cif.gz_AAA	LOKIASV2_0141_ESMFold_hypothetical_protein	7q52-assembly1.cif.gz_AAA Crystal structure of S/T protein kinase PknG from Mycobacterium tuberculosis in complex with inhibitor L2W	0.156	251	208	28	275	58	308	5.827E-05	108
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap4-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ap4-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.129	243	196	29	271	11	236	3.312E-04	107
LOKIASV2_0141_ESMFold_hypothetical_protein	6gcr-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6gcr-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with irreversible inhibitor	0.138	251	214	28	278	9	257	5.827E-05	107
LOKIASV2_0141_ESMFold_hypothetical_protein	7clh-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7clh-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 19	0.162	236	190	36	271	10	237	1.426E-04	107
LOKIASV2_0141_ESMFold_hypothetical_protein	5ia0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ia0-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with alisertib (MLN8237)	0.116	251	219	32	282	6	254	9.359E-05	107
LOKIASV2_0141_ESMFold_hypothetical_protein	6vg3-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6vg3-assembly3.cif.gz_C Structure of unliganded, inactive PTK7 kinase domain	0.128	258	213	28	272	7	264	1.761E-04	107
LOKIASV2_0141_ESMFold_hypothetical_protein	6tg1-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6tg1-assembly2.cif.gz_B Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 21b	0.125	252	212	31	273	10	261	9.359E-05	107
LOKIASV2_0141_ESMFold_hypothetical_protein	8pyk-assembly1.cif.gz_AAA	LOKIASV2_0141_ESMFold_hypothetical_protein	8pyk-assembly1.cif.gz_AAA Human IGF1R with inhibitor 47	0.150	260	179	28	238	13	272	2.415E-04	107
LOKIASV2_0141_ESMFold_hypothetical_protein	8stg-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	8stg-assembly2.cif.gz_B Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations	0.161	266	205	34	278	8	273	1.426E-04	107
LOKIASV2_0141_ESMFold_hypothetical_protein	7atu-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7atu-assembly1.cif.gz_A The LIMK1 Kinase Domain Bound To LIJTF500025	0.119	192	162	37	228	8	192	6.232E-04	107
LOKIASV2_0141_ESMFold_hypothetical_protein	4rwk-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4rwk-assembly2.cif.gz_B Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)	0.160	258	207	28	274	19	276	1.040E-04	107
LOKIASV2_0141_ESMFold_hypothetical_protein	7mfc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7mfc-assembly1.cif.gz_A Crystal structure of CSF1R in complex with vimseltinib	0.133	274	214	26	273	13	286	9.865E-05	107
LOKIASV2_0141_ESMFold_hypothetical_protein	4v05-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4v05-assembly1.cif.gz_A FGFR1 in complex with AZD4547.	0.135	247	211	28	274	14	258	1.040E-04	107
LOKIASV2_0141_ESMFold_hypothetical_protein	6itj-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6itj-assembly2.cif.gz_B Crystal structure of FGFR1 kinase domain in complex with compound 3	0.135	251	210	28	271	19	269	1.353E-04	107
LOKIASV2_0141_ESMFold_hypothetical_protein	6xva-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6xva-assembly1.cif.gz_A Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor bearing an acrylamide	0.120	270	216	28	273	20	289	8.879E-05	107
LOKIASV2_0141_ESMFold_hypothetical_protein	8pq9-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8pq9-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib	0.130	273	213	28	273	23	295	2.291E-04	107
LOKIASV2_0141_ESMFold_hypothetical_protein	3og7-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3og7-assembly1.cif.gz_A B-Raf Kinase V600E oncogenic mutant in complex with PLX4032	0.122	247	207	28	274	8	244	2.415E-04	106
LOKIASV2_0141_ESMFold_hypothetical_protein	3gfw-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3gfw-assembly1.cif.gz_A Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrolo-pyridin ligand	0.125	235	186	38	272	16	228	2.415E-04	106
LOKIASV2_0141_ESMFold_hypothetical_protein	5eho-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5eho-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.140	236	194	36	271	10	236	9.865E-05	106
LOKIASV2_0141_ESMFold_hypothetical_protein	3fzp-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3fzp-assembly1.cif.gz_A Crystal structure of PYK2 complexed with ATPgS	0.139	253	214	28	280	6	255	9.865E-05	106
LOKIASV2_0141_ESMFold_hypothetical_protein	2ijm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2ijm-assembly1.cif.gz_A Crystal Structure of Focal Adhesion Kinase Domain with 2 molecules in the Asymmetric Unit Complexed with ADP and ATP	0.118	259	224	29	283	2	260	4.030E-05	106
LOKIASV2_0141_ESMFold_hypothetical_protein	2yn8-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2yn8-assembly2.cif.gz_B ephB4 kinase domain inhibitor complex	0.139	255	212	28	282	9	255	1.096E-04	106
LOKIASV2_0141_ESMFold_hypothetical_protein	3fzo-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3fzo-assembly1.cif.gz_A Crystal Structure of PYK2-Apo, Proline-rich Tyrosine Kinase	0.133	255	218	28	280	5	259	2.174E-04	106
LOKIASV2_0141_ESMFold_hypothetical_protein	7xbr-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	7xbr-assembly2.cif.gz_C Crystal structure of phosphorylated AtMKK5	0.158	194	157	34	220	5	198	2.291E-04	106
LOKIASV2_0141_ESMFold_hypothetical_protein	6fnm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6fnm-assembly1.cif.gz_A Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with Dasatinib	0.140	258	218	28	282	7	264	1.761E-04	106
LOKIASV2_0141_ESMFold_hypothetical_protein	2qkr-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2qkr-assembly1.cif.gz_A Cryptosporidium parvum cyclin-dependent kinase cgd5_2510 with indirubin 3'-monoxime bound	0.176	163	126	29	191	2	155	2.092E-03	106
LOKIASV2_0141_ESMFold_hypothetical_protein	6pmc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6pmc-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND 1a	0.147	267	208	28	272	10	276	9.865E-05	106
LOKIASV2_0141_ESMFold_hypothetical_protein	4r1v-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4r1v-assembly1.cif.gz_A Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors	0.085	265	226	28	275	21	285	1.155E-04	106
LOKIASV2_0141_ESMFold_hypothetical_protein	3js2-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3js2-assembly2.cif.gz_B Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5-(2-thienyl)nicotinic acid	0.139	248	209	28	271	19	266	1.353E-04	106
LOKIASV2_0141_ESMFold_hypothetical_protein	5nkf-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5nkf-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 3b	0.108	276	226	31	284	4	279	1.426E-04	106
LOKIASV2_0141_ESMFold_hypothetical_protein	6jpe-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6jpe-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain with irreversible inhibitor 1	0.132	282	216	28	277	15	296	7.582E-05	106
LOKIASV2_0141_ESMFold_hypothetical_protein	6ty4-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6ty4-assembly1.cif.gz_B FAK structure with AMP-PNP from single particle analysis of 2D crystals	0.115	265	223	26	278	354	618	1.670E-04	106
LOKIASV2_0141_ESMFold_hypothetical_protein	7atu-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	7atu-assembly3.cif.gz_C The LIMK1 Kinase Domain Bound To LIJTF500025	0.122	162	136	67	228	7	162	1.373E-03	105
LOKIASV2_0141_ESMFold_hypothetical_protein	4c4i-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4c4i-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.126	236	193	36	271	10	231	2.174E-04	105
LOKIASV2_0141_ESMFold_hypothetical_protein	4d4v-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4d4v-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain	0.123	251	216	28	278	7	253	1.218E-04	105
LOKIASV2_0141_ESMFold_hypothetical_protein	5eh0-assembly1.cif.gz_A-2	LOKIASV2_0141_ESMFold_hypothetical_protein	5eh0-assembly1.cif.gz_A-2 Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.159	236	190	36	271	10	236	8.879E-05	105
LOKIASV2_0141_ESMFold_hypothetical_protein	4o6l-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4o6l-assembly1.cif.gz_A Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1H-indazole-5-carboxamide)	0.139	236	196	36	271	11	239	1.426E-04	105
LOKIASV2_0141_ESMFold_hypothetical_protein	7cil-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7cil-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 7	0.125	236	202	36	271	11	242	1.218E-04	105
LOKIASV2_0141_ESMFold_hypothetical_protein	3zzw-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3zzw-assembly1.cif.gz_A Crystal structure of the kinase domain of ROR2	0.141	264	207	32	273	4	267	1.040E-04	105
LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H	LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.141	208	177	28	234	6	213	7.298E-04	105
LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly2.cif.gz_B Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.143	164	135	28	191	7	164	3.936E-03	105
LOKIASV2_0141_ESMFold_hypothetical_protein	5zv2-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5zv2-assembly2.cif.gz_B FGFR-1 in complex with ligand lenvatinib	0.144	258	211	28	274	18	275	1.353E-04	105
LOKIASV2_0141_ESMFold_hypothetical_protein	7v3r-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7v3r-assembly1.cif.gz_A Crystal structure of CMET in complex with a novel inhibitor	0.087	198	175	28	220	23	220	7.298E-04	105
LOKIASV2_0141_ESMFold_hypothetical_protein	5am7-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5am7-assembly2.cif.gz_B FGFR1 mutant with an inhibitor	0.150	242	203	28	269	20	259	1.585E-04	105
LOKIASV2_0141_ESMFold_hypothetical_protein	3qqu-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3qqu-assembly2.cif.gz_B Cocrystal structure of unphosphorylated igf with pyrimidine 8	0.138	241	204	32	269	8	248	1.218E-04	105
LOKIASV2_0141_ESMFold_hypothetical_protein	5o4a-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5o4a-assembly2.cif.gz_B Human FGF in complex with a covalent inhibitor	0.155	268	208	28	274	18	285	1.096E-04	105
LOKIASV2_0141_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A Crystal structure of SU6656-bound calcium/calmodulin-dependent protein kinase II delta in complex with calmodulin	0.117	247	211	28	274	5	244	3.680E-04	105
LOKIASV2_0141_ESMFold_hypothetical_protein	2j0k-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2j0k-assembly2.cif.gz_B Crystal structure of a fragment of focal adhesion kinase containing the FERM and kinase domains.	0.137	251	214	28	278	361	609	8.424E-05	105
LOKIASV2_0141_ESMFold_hypothetical_protein	7kxw-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7kxw-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with DCLK1-IN-1	0.116	258	197	14	271	4	227	2.546E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	4bi2-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4bi2-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	0.130	243	192	29	271	10	231	2.062E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	2jko-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2jko-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor	0.127	251	215	28	278	7	253	6.824E-05	104
LOKIASV2_0141_ESMFold_hypothetical_protein	5nad-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5nad-assembly1.cif.gz_A TTK kinase domain in complex with BAY 1217389	0.139	236	194	36	271	10	235	9.359E-05	104
LOKIASV2_0141_ESMFold_hypothetical_protein	6yr9-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6yr9-assembly2.cif.gz_B FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-Methyl-N-(2-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-phenyl)-methanesulfonamide	0.123	253	220	26	278	6	257	7.193E-05	104
LOKIASV2_0141_ESMFold_hypothetical_protein	7chm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7chm-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 8	0.158	233	183	40	272	18	235	1.956E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	4nwm-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4nwm-assembly2.cif.gz_B Crystal structure of Bruton agammaglobulinemia tyrosine kinase complexed with BMS-809959 aka 4-tert-butyl-n-[2-me thyl-3-(6-{[4-(morpholine-4-carbonyl)phenyl]amino}-9h- purin-2-yl)phenyl]benzamide	0.109	257	217	31	274	3	259	7.582E-05	104
LOKIASV2_0141_ESMFold_hypothetical_protein	3h3c-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3h3c-assembly1.cif.gz_A Crystal structure of PYK2 in complex with Sulfoximine-substituted trifluoromethylpyrimidine analog	0.146	250	211	28	277	9	256	8.424E-05	104
LOKIASV2_0141_ESMFold_hypothetical_protein	7cja-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7cja-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 28	0.136	232	191	40	271	19	240	1.670E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	4k9y-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4k9y-assembly1.cif.gz_A FOCAL ADHESION KINASE Catalytic domain in complex with 1-[4-(6-Amino-purin-9-yl)-phenyl]-3-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-urea	0.125	263	219	28	278	7	269	4.975E-05	104
LOKIASV2_0141_ESMFold_hypothetical_protein	6nvh-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6nvh-assembly1.cif.gz_A FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	0.134	257	216	28	277	14	270	1.503E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	6fer-assembly5.cif.gz_E	LOKIASV2_0141_ESMFold_hypothetical_protein	6fer-assembly5.cif.gz_E Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	0.115	199	165	32	219	7	205	4.089E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	5l6p-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5l6p-assembly1.cif.gz_A EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 6)	0.105	270	221	35	282	1	270	1.353E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	6c19-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6c19-assembly1.cif.gz_A FGFR1 kinase complex with inhibitor SN36985	0.143	255	181	28	239	14	268	5.912E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	7qhg-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7qhg-assembly2.cif.gz_B LIM domain kinase 2 (LIMK2) in complex with TH-470	0.123	266	207	48	284	18	283	6.824E-05	104
LOKIASV2_0141_ESMFold_hypothetical_protein	4zy5-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4zy5-assembly1.cif.gz_A Crystal Structure of p21-activated kinase 1 in complex with an inhibitor compound 17	0.135	241	203	37	272	23	263	3.492E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	8pyi-assembly7.cif.gz_GGG	LOKIASV2_0141_ESMFold_hypothetical_protein	8pyi-assembly7.cif.gz_GGG Human IGF1R with inhibitor 6	0.148	236	199	34	269	11	245	2.062E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24	0.147	235	179	36	270	3	213	3.879E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	6nsp-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6nsp-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND 9	0.130	271	212	28	272	10	280	1.585E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	3cth-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3cth-assembly1.cif.gz_A Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a aminopyridine based inhibitor	0.107	258	219	32	277	21	278	9.359E-05	104
LOKIASV2_0141_ESMFold_hypothetical_protein	5wr7-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5wr7-assembly1.cif.gz_A Crystal structure of Trk-A complexed with a selective inhibitor CH7057288	0.119	274	217	28	274	21	294	2.415E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	6il3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6il3-assembly1.cif.gz_A Crystal structure of the FLT3 kinase bound to a small molecule inhibitor	0.160	249	204	28	271	41	289	3.680E-04	104
LOKIASV2_0141_ESMFold_hypothetical_protein	7kx8-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7kx8-assembly2.cif.gz_B Crystal structure of DCLK1-Cter in complex with FMF-03-055-1	0.103	199	161	28	226	10	189	9.496E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	6gcw-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6gcw-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with irreversible inhibitor	0.113	251	216	28	278	8	252	9.359E-05	103
LOKIASV2_0141_ESMFold_hypothetical_protein	4o6l-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4o6l-assembly2.cif.gz_B Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1H-indazole-5-carboxamide)	0.140	235	189	37	271	15	235	2.683E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	3hmp-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3hmp-assembly1.cif.gz_A Crystal structure of human Mps1 catalytic domain in complex with a quinazolin ligand Compound 4	0.144	234	189	38	271	15	236	2.062E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	6vzk-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6vzk-assembly1.cif.gz_A Crystal structure of human CaMKII-alpha (CAMK2A)kinase domain	0.121	250	171	28	222	6	255	1.303E-03	103
LOKIASV2_0141_ESMFold_hypothetical_protein	6tn9-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6tn9-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 16	0.129	243	195	29	271	13	237	2.546E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	5n9s-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5n9s-assembly1.cif.gz_A TTK kinase domain in complex with BAY 1161909	0.141	232	189	38	269	15	235	2.546E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	2etm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2etm-assembly1.cif.gz_A Crystal Structure of Focal Adhesion Kinase Domain Complexed with 7H-Pyrrolo [2,3-d] pyrimidine Derivative	0.127	256	211	32	274	4	259	4.975E-05	103
LOKIASV2_0141_ESMFold_hypothetical_protein	5igu-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5igu-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II	0.119	262	197	48	272	2	263	7.298E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	5l6o-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5l6o-assembly1.cif.gz_A EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 3)	0.119	262	223	29	282	2	263	2.828E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	6n0p-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6n0p-assembly1.cif.gz_A BRAF in complex with N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide (LXH254)	0.127	260	217	28	277	8	267	3.142E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	6nvj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6nvj-assembly1.cif.gz_A FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-fluorophenyl)acrylamide	0.131	255	216	28	277	14	268	2.828E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	8eme-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	8eme-assembly1.cif.gz_B EGFR(T790M/V948R) in complex with ZNL-0056	0.116	246	215	31	274	6	251	7.992E-05	103
LOKIASV2_0141_ESMFold_hypothetical_protein	4eev-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4eev-assembly1.cif.gz_A Crystal structure of c-Met in complex with LY2801653	0.099	193	168	28	220	31	217	1.112E-03	103
LOKIASV2_0141_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A CaMKII Substrate Complex A	0.112	252	216	23	274	2	245	5.048E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	4xs2-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	4xs2-assembly3.cif.gz_C Irak4-inhibitor co-structure	0.144	247	193	48	274	35	281	4.310E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	1jqh-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	1jqh-assembly2.cif.gz_B IGF-1 receptor kinase domain	0.157	213	170	32	234	12	224	3.142E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	5sav-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5sav-assembly1.cif.gz_A DDR1, N-[2-[3-(2-aminopyrimidin-5-yl)oxyphenyl]ethyl]-3-(trifluoromethoxy)benzamide, 1.760A, P212121, Rfree=23.5%	0.115	214	169	28	219	8	221	4.310E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	6w4p-assembly1.cif.gz_H	LOKIASV2_0141_ESMFold_hypothetical_protein	6w4p-assembly1.cif.gz_H CaMKII alpha-30 Cryo-EM reconstruction - Class B	0.119	286	219	24	273	2	287	3.680E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	5a46-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5a46-assembly2.cif.gz_B FGFR1 in complex with dovitinib	0.153	250	206	28	271	20	269	2.828E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	6duk-assembly3.cif.gz_F	LOKIASV2_0141_ESMFold_hypothetical_protein	6duk-assembly3.cif.gz_F EGFR with an allosteric inhibitor	0.116	256	222	28	283	11	262	1.426E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	4uwb-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4uwb-assembly2.cif.gz_B Fibroblast growth factor receptor 1 kinase in complex with JK-P5	0.143	252	211	28	274	19	270	1.670E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	7p1l-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7p1l-assembly2.cif.gz_B The MARK3 Kinase Domain Bound To AA-CS-1-008	0.126	197	166	28	218	6	202	4.543E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	6u6a-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6u6a-assembly1.cif.gz_A Crystal structure of Yck2 from Candida albicans in complex with kinase inhibitor GW461484A	0.142	275	215	28	278	7	281	2.415E-04	103
LOKIASV2_0141_ESMFold_hypothetical_protein	4d2s-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4d2s-assembly1.cif.gz_A Human TTK in complex with a Dyrk1B inhibitor	0.125	243	188	29	271	13	228	2.415E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	6uuo-assembly2.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6uuo-assembly2.cif.gz_A Crystal structure of BRAF kinase domain bound to the PROTAC P4B	0.136	243	194	32	274	4	228	1.284E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	3kl8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3kl8-assembly1.cif.gz_A CaMKIINtide Inhibitor Complex	0.116	146	123	42	181	1	146	4.859E-03	102
LOKIASV2_0141_ESMFold_hypothetical_protein	6h3k-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6h3k-assembly1.cif.gz_A Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enables the discovery of the Phase 1 clinical candidate BOS172722.	0.140	236	194	36	271	10	235	1.761E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	3hmo-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3hmo-assembly1.cif.gz_A Crystal structure of human Mps1 catalytic domain in complex with the inhibitor staurosporine	0.136	243	193	29	271	12	235	2.291E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	4c4j-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4c4j-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.141	240	201	37	271	1	240	2.062E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	5ei6-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ei6-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.130	236	202	36	271	10	242	1.761E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	7m5z-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7m5z-assembly2.cif.gz_B Crystal Structure of the MerTK Kinase Domain in Complex with Inhibitor MIPS15692	0.139	250	214	28	277	13	262	3.680E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	6gvj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6gvj-assembly1.cif.gz_A Human Mps1 kinase domain with ordered activation loop	0.131	248	205	35	271	2	249	2.546E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	7lg8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7lg8-assembly1.cif.gz_A EGFR (T79M/V948R) in complex with naquotinib and an allosteric inhibitor	0.121	247	215	28	274	10	255	2.291E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	5zv2-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5zv2-assembly1.cif.gz_A FGFR-1 in complex with ligand lenvatinib	0.139	245	209	28	271	15	259	3.142E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	5eob-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5eob-assembly1.cif.gz_A Crystal structure of CMET in complex with novel inhibitor	0.102	266	224	28	277	21	286	3.312E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	6bab-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6bab-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	0.126	284	214	28	273	3	286	2.683E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	3c4f-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3c4f-assembly2.cif.gz_B FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-methoxybenzyl)-7-azaindole	0.153	249	206	28	271	14	262	2.174E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	5a4c-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5a4c-assembly1.cif.gz_A FGFR1 ligand complex	0.141	258	210	29	274	8	265	1.856E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	7ybp-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7ybp-assembly1.cif.gz_A Crystal structure of FGFR4(V550L) kinase domain with 10z	0.135	284	215	28	277	14	297	1.956E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	3vw8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3vw8-assembly1.cif.gz_A Crystal structure of human c-Met kinase domain with its inhibitor	0.110	258	190	28	242	37	294	1.001E-03	102
LOKIASV2_0141_ESMFold_hypothetical_protein	3ndm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3ndm-assembly1.cif.gz_A Crystal structure of Rho-Associated Protein Kinase (ROCK1) with a potent isoquinolone derivative	0.108	211	182	13	217	50	260	8.109E-04	102
LOKIASV2_0141_ESMFold_hypothetical_protein	5ei2-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ei2-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.140	243	193	29	271	10	234	4.089E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	2zmd-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2zmd-assembly1.cif.gz_A Crystal structure of human Mps1 catalytic domain T686A mutant in complex with SP600125 inhibitor	0.136	236	195	36	271	10	236	2.174E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	6mzq-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6mzq-assembly2.cif.gz_B TAS-120 in reversible binding mode with FGFR1	0.146	244	188	28	271	16	236	2.546E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	4zeg-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4zeg-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with a pyrazolopyrimidine inhibitor	0.133	236	197	36	271	10	237	1.670E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	5ap6-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ap6-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.146	236	196	36	271	10	240	1.856E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	3efl-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3efl-assembly2.cif.gz_B Crystal structure of the VEGFR2 kinase domain in complex with motesanib	0.145	249	210	28	274	13	261	3.312E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	5wni-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5wni-assembly1.cif.gz_A Crystal structure of murine receptor-interacting protein kinase 4 (Ripk4) D143N in complex with ATP	0.120	245	208	38	274	17	261	4.310E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	7chn-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7chn-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 9	0.134	236	200	36	271	11	242	1.585E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	8hmt-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	8hmt-assembly2.cif.gz_B The complex of ACK1 with the inhibitor 2-142	0.116	261	211	34	273	8	268	4.789E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	7juz-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7juz-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Selumetinib	0.099	243	215	29	271	13	252	1.856E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	2vx1-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2vx1-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.122	270	221	32	284	4	273	2.291E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	8xfm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8xfm-assembly1.cif.gz_A The Crystal Structure of MNK2 from Biortus.	0.143	265	210	29	274	11	275	1.172E-03	101
LOKIASV2_0141_ESMFold_hypothetical_protein	2ac3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2ac3-assembly1.cif.gz_A Structure of human Mnk2 Kinase Domain	0.168	217	156	29	217	14	230	1.985E-03	101
LOKIASV2_0141_ESMFold_hypothetical_protein	6jol-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6jol-assembly1.cif.gz_A Crystal structure of PDGFRA in complex with imatinib by co-crystallization	0.143	266	211	28	274	10	275	3.142E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	6c1o-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6c1o-assembly1.cif.gz_A FGFR1 kinase domain complexed with FIIN-1	0.163	259	206	28	274	14	272	2.683E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	4u45-assembly2.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4u45-assembly2.cif.gz_A MAP4K4 in complex with inhibitor (compound 25)	0.111	274	218	28	273	13	286	5.609E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	6xvb-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6xvb-assembly1.cif.gz_A Crystal structure of the kinase domain of human c-KIT with a cyclic imidate inhibitor covalently bound to Cys788	0.120	273	216	28	273	20	292	3.492E-04	101
LOKIASV2_0141_ESMFold_hypothetical_protein	6tnb-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6tnb-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 41	0.130	237	193	35	271	8	230	2.415E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2	LOKIASV2_0141_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2 Aurora A ligand complex	0.141	247	204	28	274	5	242	4.089E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	2x9e-assembly1.cif.gz_A-2	LOKIASV2_0141_ESMFold_hypothetical_protein	2x9e-assembly1.cif.gz_A-2 HUMAN MPS1 IN COMPLEX WITH NMS-P715	0.143	234	180	39	272	18	228	2.546E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	4cva-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4cva-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	0.136	243	192	29	271	11	233	3.680E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	7khj-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7khj-assembly2.cif.gz_B Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX8512 in the DFG-in state	0.127	246	210	32	272	15	260	4.543E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	5xfj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5xfj-assembly1.cif.gz_A Crystal structure of LY2874455 in complex of FGFR4 gatekeeper mutation (V550M)	0.135	251	191	28	249	14	264	4.543E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	5ia4-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ia4-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with foretinib (XL880)	0.109	263	217	31	274	4	266	1.503E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	4d4r-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4d4r-assembly2.cif.gz_B Focal Adhesion Kinase catalytic domain	0.131	260	217	28	278	10	269	4.975E-05	100
LOKIASV2_0141_ESMFold_hypothetical_protein	4xuf-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4xuf-assembly1.cif.gz_A Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)	0.160	258	205	28	272	10	267	3.879E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_B TRK-A IN COMPLEX WITH LIGAND	0.130	258	211	31	274	7	264	2.415E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	5jfx-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5jfx-assembly1.cif.gz_A Crystal structure of TrkA in complex with PF-06273340	0.138	248	212	28	274	21	268	3.492E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	6kzd-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6kzd-assembly1.cif.gz_A Crystal structure of TRKc in complex with 3-((6-(4-aminophenyl)imidazo[1,2-a]pyrazin-3-yl)ethynyl)- N-(3-isopropyl-5-((4-methylpiperazin-1-yl)methyl)phenyl)-2- methylbenzamide	0.150	263	209	28	274	10	272	3.680E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	4nk9-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4nk9-assembly1.cif.gz_B Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 1	0.141	244	203	28	271	18	254	3.680E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	4obp-assembly3.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4obp-assembly3.cif.gz_A MAP4K4 in complex with inhibitor (compound 29), 6-(2-FLUOROPYRIDIN-4-YL)PYRIDO[3,2-D]PYRIMIDIN-4-AMINE	0.118	271	209	36	273	13	283	1.585E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_A Crystal structure of unactivated c-KIT in complex with compound	0.149	276	210	26	273	24	299	3.142E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	4umr-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4umr-assembly1.cif.gz_A Structure of MELK in complex with inhibitors	0.152	244	186	28	271	5	224	8.109E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	3vwa-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3vwa-assembly1.cif.gz_A Crystal structure of Cex1p	0.140	273	225	21	283	5	277	2.291E-04	100
LOKIASV2_0141_ESMFold_hypothetical_protein	6c18-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6c18-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37115	0.147	249	183	29	243	6	254	7.298E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	3u51-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3u51-assembly1.cif.gz_A Src in complex with DNA-templated macrocyclic inhibitor MC1	0.134	254	217	30	283	1	251	2.546E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	6m7z-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6m7z-assembly2.cif.gz_B A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.134	164	133	66	229	67	221	1.525E-03	99
LOKIASV2_0141_ESMFold_hypothetical_protein	3wzk-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3wzk-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH N-cyclopropyl-4-(8-((thiophen-2-ylmethyl)amino)imidazo[1,2-a]pyrazin-3-yl)benzamide	0.156	239	190	36	274	10	235	2.546E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	5n7v-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5n7v-assembly1.cif.gz_A TTK kinase domain in complex with MPI-0479605	0.144	236	196	36	271	10	239	2.981E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_A Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.121	239	184	25	234	4	242	2.981E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	6fnh-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6fnh-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712	0.136	259	209	31	273	7	265	1.670E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	6yky-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6yky-assembly1.cif.gz_A Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	0.123	255	207	35	271	5	259	1.761E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	4neu-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4neu-assembly1.cif.gz_A X-ray structure of Receptor Interacting Protein 1 (RIP1)kinase domain with a 1-aminoisoquinoline inhibitor	0.127	278	212	30	273	6	283	5.912E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	4zk5-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4zk5-assembly1.cif.gz_A MAP4K4 in complex with inhibitor GNE-495	0.115	275	210	36	273	9	283	3.142E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	5say-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5say-assembly2.cif.gz_B DDR1, N-[2-[3-(2-aminopyrimidin-5-yl)oxyphenyl]ethyl]-3-(trifluoromethoxy)benzamide, 2.190A, P1211, Rfree=27.7%	0.120	206	172	28	223	8	213	1.608E-03	99
LOKIASV2_0141_ESMFold_hypothetical_protein	4tye-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4tye-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	0.113	274	222	28	278	16	289	2.683E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	6xv9-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6xv9-assembly2.cif.gz_B Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor	0.117	271	216	28	273	17	287	1.096E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	7zy6-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7zy6-assembly1.cif.gz_A Identification of M4205 a highly selective inhibitor of cKIT mutations for unresectable metastatic or recurrent GIST	0.117	271	221	28	278	22	292	3.312E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	6hp9-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6hp9-assembly1.cif.gz_A Structure of the kinase domain of human DDR1 in complex with a 2-Amino-2,3-Dihydro-1H-Indene-5-Carboxamide-based inhibitor	0.144	225	162	38	227	11	235	3.312E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	3wze-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3wze-assembly1.cif.gz_A KDR in complex with ligand sorafenib	0.149	281	214	26	277	17	297	3.492E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	8h7x-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	8h7x-assembly1.cif.gz_B Crystal structure of EGFR T790M/C797S mutant in complex with brigatinib	0.117	257	216	28	273	15	271	2.546E-04	99
LOKIASV2_0141_ESMFold_hypothetical_protein	4yzc-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4yzc-assembly2.cif.gz_B Crystal structure of pIRE1alpha in complex with staurosporine	0.110	153	121	28	180	7	143	3.543E-03	99
LOKIASV2_0141_ESMFold_hypothetical_protein	5ubr-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ubr-assembly1.cif.gz_A CRYSTAL STRUCTURE OF PI3K ALPHA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1-YL)PHENYL)PYRROLO[2,1-F][1,2,4] TRIAZIN-4-AMINE DERIVIATINE	0.147	270	208	30	274	614	883	4.248E-05	99
LOKIASV2_0141_ESMFold_hypothetical_protein	4jbq-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4jbq-assembly1.cif.gz_A Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules	0.147	247	201	28	274	7	243	6.232E-04	98
LOKIASV2_0141_ESMFold_hypothetical_protein	7xbr-assembly2.cif.gz_F	LOKIASV2_0141_ESMFold_hypothetical_protein	7xbr-assembly2.cif.gz_F Crystal structure of phosphorylated AtMKK5	0.158	187	157	34	220	5	191	1.856E-04	98
LOKIASV2_0141_ESMFold_hypothetical_protein	2zmc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2zmc-assembly1.cif.gz_A Crystal structure of human mitotic checkpoint kinase Mps1 catalytic domain apo form	0.128	238	206	35	271	1	238	4.789E-04	98
LOKIASV2_0141_ESMFold_hypothetical_protein	2z2w-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2z2w-assembly1.cif.gz_A Human Wee1 kinase complexed with inhibitor PF0335770	0.111	213	179	33	234	6	218	8.547E-04	98
LOKIASV2_0141_ESMFold_hypothetical_protein	6mzq-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6mzq-assembly1.cif.gz_A TAS-120 in reversible binding mode with FGFR1	0.151	244	200	28	271	14	250	3.312E-04	98
LOKIASV2_0141_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	0.118	283	215	29	273	7	289	2.981E-04	98
LOKIASV2_0141_ESMFold_hypothetical_protein	2xir-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2xir-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with PF- 00337210 (N,2-dimethyl-6-(7-(2-morpholinoethoxy)quinolin-4-yloxy) benzofuran-3-carboxamide)	0.148	277	212	28	277	18	294	5.048E-04	98
LOKIASV2_0141_ESMFold_hypothetical_protein	4bky-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4bky-assembly1.cif.gz_A Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with pyrrolopyrazole inhibitor	0.160	244	180	28	271	8	222	4.089E-04	98
LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly5.cif.gz_E	LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly5.cif.gz_E Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.138	193	165	28	220	6	197	1.112E-03	98
LOKIASV2_0141_ESMFold_hypothetical_protein	2jav-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2jav-assembly1.cif.gz_A Human Kinase with pyrrole-indolinone ligand	0.104	196	159	28	223	5	183	1.172E-03	97
LOKIASV2_0141_ESMFold_hypothetical_protein	3cr0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3cr0-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD259_809	0.123	176	151	47	219	18	193	2.205E-03	97
LOKIASV2_0141_ESMFold_hypothetical_protein	3wzj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3wzj-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(6-(cyclohexylamino)-8-(((tetrahydro-2H-pyran-4-yl)methyl)amino)imidazo[1,2-b]pyridazin-3-yl)-N-cyclopropylbenzamide	0.145	237	200	35	271	1	235	1.856E-04	97
LOKIASV2_0141_ESMFold_hypothetical_protein	6c19-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6c19-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN36985	0.150	242	195	28	269	7	236	5.048E-04	97
LOKIASV2_0141_ESMFold_hypothetical_protein	3g6g-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3g6g-assembly1.cif.gz_A Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations	0.138	256	214	28	283	11	259	4.310E-04	97
LOKIASV2_0141_ESMFold_hypothetical_protein	7khk-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7khk-assembly2.cif.gz_B Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX9486 (bezuclastinib) in the DFG-in state	0.140	247	212	32	278	19	265	1.172E-03	97
LOKIASV2_0141_ESMFold_hypothetical_protein	6bab-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6bab-assembly3.cif.gz_C The structure of human CamKII with bound inhibitor	0.117	246	207	29	274	2	236	5.912E-04	97
LOKIASV2_0141_ESMFold_hypothetical_protein	5grn-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5grn-assembly1.cif.gz_A Crystal structure of PDGFRA in Complex with WQ-C-159	0.135	272	213	28	274	9	280	9.009E-04	97
LOKIASV2_0141_ESMFold_hypothetical_protein	6xvb-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6xvb-assembly2.cif.gz_B Crystal structure of the kinase domain of human c-KIT with a cyclic imidate inhibitor covalently bound to Cys788	0.122	276	215	28	273	12	287	4.543E-04	97
LOKIASV2_0141_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A Structure of the N-terminal domain of SAD	0.112	195	159	28	222	11	190	2.325E-03	97
LOKIASV2_0141_ESMFold_hypothetical_protein	3vrz-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3vrz-assembly2.cif.gz_B Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea	0.126	243	195	32	274	175	398	2.828E-04	97
LOKIASV2_0141_ESMFold_hypothetical_protein	6n6o-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6n6o-assembly1.cif.gz_A Crystal structure of the human TTK in complex with an inhibitor	0.159	234	177	39	272	18	229	5.609E-04	96
LOKIASV2_0141_ESMFold_hypothetical_protein	5n93-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5n93-assembly1.cif.gz_A TTK kinase domain in complex with TC-Mps1-12	0.144	236	195	36	271	10	238	5.321E-04	96
LOKIASV2_0141_ESMFold_hypothetical_protein	6c18-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6c18-assembly1.cif.gz_A FGFR1 kinase complex with inhibitor SN37115	0.172	262	174	29	239	7	268	7.298E-04	96
LOKIASV2_0141_ESMFold_hypothetical_protein	8pym-assembly1.cif.gz_AAA	LOKIASV2_0141_ESMFold_hypothetical_protein	8pym-assembly1.cif.gz_AAA Human IGF1R with inhibitor 54	0.134	263	207	34	273	14	276	2.683E-04	96
LOKIASV2_0141_ESMFold_hypothetical_protein	6dki-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6dki-assembly1.cif.gz_A Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 19.	0.139	262	209	31	274	6	267	3.312E-04	96
LOKIASV2_0141_ESMFold_hypothetical_protein	6iup-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6iup-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with compound 5	0.128	273	217	28	277	15	287	1.426E-04	96
LOKIASV2_0141_ESMFold_hypothetical_protein	3eta-assembly3.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3eta-assembly3.cif.gz_B Kinase domain of insulin receptor complexed with a pyrrolo pyridine inhibitor	0.133	229	177	30	234	1	229	4.789E-04	96
LOKIASV2_0141_ESMFold_hypothetical_protein	4uwb-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4uwb-assembly1.cif.gz_A Fibroblast growth factor receptor 1 kinase in complex with JK-P5	0.143	278	211	28	274	14	291	4.789E-04	96
LOKIASV2_0141_ESMFold_hypothetical_protein	7b3m-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7b3m-assembly1.cif.gz_A MEK1 in complex with compound 6	0.144	213	179	1	213	3	212	5.912E-04	96
LOKIASV2_0141_ESMFold_hypothetical_protein	5mai-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5mai-assembly1.cif.gz_A Crystal structure of MELK in complex with an inhibitor	0.164	198	145	16	213	2	176	2.723E-03	96
LOKIASV2_0141_ESMFold_hypothetical_protein	5dxh-assembly2.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	5dxh-assembly2.cif.gz_D p110alpha/p85alpha with compound 5	0.136	258	218	30	282	711	968	3.627E-05	96
LOKIASV2_0141_ESMFold_hypothetical_protein	4xv3-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4xv3-assembly1.cif.gz_B B-Raf Kinase V600E oncogenic mutant in complex with PLX7922	0.134	239	197	36	274	10	237	6.568E-04	95
LOKIASV2_0141_ESMFold_hypothetical_protein	7cht-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7cht-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 30	0.131	234	193	38	271	17	239	4.089E-04	95
LOKIASV2_0141_ESMFold_hypothetical_protein	4ehe-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4ehe-assembly1.cif.gz_A B-Raf Kinase Domain in Complex with an Aminothienopyrimidine-based Inhibitor	0.135	255	215	28	277	9	263	5.912E-04	95
LOKIASV2_0141_ESMFold_hypothetical_protein	5o91-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5o91-assembly1.cif.gz_A Crystal structure of human Mps1 (TTK) C604W mutant in complex with Cpd-5	0.131	242	205	35	271	1	242	3.142E-04	95
LOKIASV2_0141_ESMFold_hypothetical_protein	4qqt-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4qqt-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Tyrosine Kinase Domain	0.127	270	217	28	277	13	282	3.312E-04	95
LOKIASV2_0141_ESMFold_hypothetical_protein	4hw7-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4hw7-assembly1.cif.gz_A Crystal structure of FMS kinase domain with a small molecular inhibitor, PLX647-OME	0.130	274	215	26	273	14	287	6.232E-04	95
LOKIASV2_0141_ESMFold_hypothetical_protein	4mxc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4mxc-assembly1.cif.gz_A Crystal structure of CMET in complex with novel inhibitor	0.116	264	220	28	277	24	287	8.109E-04	95
LOKIASV2_0141_ESMFold_hypothetical_protein	4r7i-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4r7i-assembly1.cif.gz_A Crystal structure of FMS kinase domain with a small molecular inhibitor, GLEEVEC	0.130	274	213	28	273	15	288	2.062E-04	95
LOKIASV2_0141_ESMFold_hypothetical_protein	3ky2-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3ky2-assembly1.cif.gz_A Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domain	0.142	266	208	28	271	15	280	6.924E-04	95
LOKIASV2_0141_ESMFold_hypothetical_protein	2bdw-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2bdw-assembly1.cif.gz_B Crystal Structure of the Auto-Inhibited Kinase Domain of Calcium/Calmodulin Activated Kinase II	0.107	294	226	28	281	4	297	3.492E-04	95
LOKIASV2_0141_ESMFold_hypothetical_protein	6tnd-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6tnd-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 79	0.141	240	198	35	274	1	232	5.912E-04	94
LOKIASV2_0141_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H	LOKIASV2_0141_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.104	233	190	32	244	3	235	6.568E-04	94
LOKIASV2_0141_ESMFold_hypothetical_protein	1jpa-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	1jpa-assembly2.cif.gz_B Crystal Structure of unphosphorylated EphB2 receptor tyrosine kinase and juxtamembrane region	0.108	270	226	13	282	14	267	8.547E-04	94
LOKIASV2_0141_ESMFold_hypothetical_protein	5o26-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5o26-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in complex with AMP-PNP/Mg2+	0.121	151	129	28	178	11	158	3.361E-03	94
LOKIASV2_0141_ESMFold_hypothetical_protein	8pyl-assembly1.cif.gz_AAA	LOKIASV2_0141_ESMFold_hypothetical_protein	8pyl-assembly1.cif.gz_AAA Human IGF1R with inhibitor 53	0.136	201	161	34	220	12	212	1.303E-03	94
LOKIASV2_0141_ESMFold_hypothetical_protein	7y4t-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7y4t-assembly1.cif.gz_A Crystal structure of cMET kinase domain bound by compound 9I	0.081	203	176	28	219	13	215	3.361E-03	94
LOKIASV2_0141_ESMFold_hypothetical_protein	6ylc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6ylc-assembly1.cif.gz_A Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	0.124	255	213	28	271	5	259	2.981E-04	94
LOKIASV2_0141_ESMFold_hypothetical_protein	2wtk-assembly1.cif.gz_E	LOKIASV2_0141_ESMFold_hypothetical_protein	2wtk-assembly1.cif.gz_E Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	0.086	224	173	28	217	6	229	5.399E-03	94
LOKIASV2_0141_ESMFold_hypothetical_protein	1t45-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	1t45-assembly1.cif.gz_A STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE	0.126	288	220	28	280	42	329	4.543E-04	94
LOKIASV2_0141_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B Pseudo-atomic model of the CaMKIIa holoenzyme.	0.116	288	220	29	278	2	289	5.609E-04	94
LOKIASV2_0141_ESMFold_hypothetical_protein	5fi4-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5fi4-assembly1.cif.gz_A Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model	0.132	272	219	30	282	718	989	7.992E-05	94
LOKIASV2_0141_ESMFold_hypothetical_protein	4r5y-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4r5y-assembly1.cif.gz_A The complex structure of Braf V600E kinase domain with a novel Braf inhibitor	0.134	247	210	28	274	8	250	1.236E-03	93
LOKIASV2_0141_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.143	247	203	28	274	6	243	9.009E-04	93
LOKIASV2_0141_ESMFold_hypothetical_protein	5d7v-assembly4.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	5d7v-assembly4.cif.gz_D Crystal structure of PTK6 kinase domain	0.125	255	215	28	274	6	260	5.609E-04	93
LOKIASV2_0141_ESMFold_hypothetical_protein	7ah3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7ah3-assembly1.cif.gz_A Kinase domain of cSrc in complex with a pyrazolopyrimidine	0.123	256	219	28	283	10	260	6.924E-04	93
LOKIASV2_0141_ESMFold_hypothetical_protein	2hyy-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2hyy-assembly2.cif.gz_B Human Abl kinase domain in complex with imatinib (STI571, Glivec)	0.133	256	214	28	275	9	264	4.543E-04	93
LOKIASV2_0141_ESMFold_hypothetical_protein	6dkb-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6dkb-assembly1.cif.gz_A Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 10b.	0.148	260	218	28	284	9	268	5.321E-04	93
LOKIASV2_0141_ESMFold_hypothetical_protein	3tv6-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3tv6-assembly2.cif.gz_B Human B-Raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor	0.137	262	212	28	274	9	270	6.232E-04	93
LOKIASV2_0141_ESMFold_hypothetical_protein	8xfl-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	8xfl-assembly2.cif.gz_B The Crystal Structure of MARK4 from Biortus.	0.119	270	222	27	279	4	273	6.568E-04	93
LOKIASV2_0141_ESMFold_hypothetical_protein	6dkw-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6dkw-assembly1.cif.gz_A Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 3.	0.142	255	211	28	274	21	275	5.912E-04	93
LOKIASV2_0141_ESMFold_hypothetical_protein	7v3s-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7v3s-assembly1.cif.gz_A Crystal structure of CMET in complex with a novel inhibitor	0.082	196	176	28	220	23	218	1.172E-03	93
LOKIASV2_0141_ESMFold_hypothetical_protein	3we4-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3we4-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a pyrimidine derivative PF-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-benzimidazole	0.139	220	162	30	218	1	220	2.092E-03	93
LOKIASV2_0141_ESMFold_hypothetical_protein	4uwc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4uwc-assembly1.cif.gz_A Fibroblast growth factor receptor 1 kinase in complex with JK-P3	0.144	259	211	28	274	13	271	1.001E-03	93
LOKIASV2_0141_ESMFold_hypothetical_protein	5xgn-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5xgn-assembly1.cif.gz_B Crystal structure of EGFR 696-1022 T790M/C797S in complex with Go6976	0.126	261	215	34	280	14	274	6.924E-04	93
LOKIASV2_0141_ESMFold_hypothetical_protein	3bea-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3bea-assembly1.cif.gz_A cFMS tyrosine kinase (tie2 KID) in complex with a pyrimidinopyridone inhibitor	0.135	267	212	28	273	35	301	9.009E-04	93
LOKIASV2_0141_ESMFold_hypothetical_protein	6p8q-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6p8q-assembly2.cif.gz_C EGFR in complex with a dihydrodibenzodiazepinone allosteric inhibitor.	0.119	262	214	31	274	9	270	2.828E-04	93
LOKIASV2_0141_ESMFold_hypothetical_protein	4hzs-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4hzs-assembly2.cif.gz_B Crystal structure of Ack1 kinase domain with C-terminal SH3 domain	0.135	255	210	31	274	7	261	5.321E-04	93
LOKIASV2_0141_ESMFold_hypothetical_protein	4q5e-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4q5e-assembly1.cif.gz_A Shigella Effector Kinase OspG bound to E2-Ub UbcH7-Ub Conjugate	0.128	188	140	37	224	6	166	1.393E-02	92
LOKIASV2_0141_ESMFold_hypothetical_protein	4xv1-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4xv1-assembly1.cif.gz_A B-Raf Kinase V600E oncogenic mutant in complex with PLX7904	0.128	247	184	28	274	8	219	1.787E-03	92
LOKIASV2_0141_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A Complex of Aurora-A bound to an Imidazopyridine-based inhibitor	0.145	247	193	28	274	7	233	1.303E-03	92
LOKIASV2_0141_ESMFold_hypothetical_protein	6cz3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6cz3-assembly1.cif.gz_A Structure of the PTK6 kinase domain bound to a type I inhibitor (3-fluoro-4-{[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino}phenyl)(morpholin-4-yl)methanone	0.153	200	165	28	227	9	204	1.985E-03	92
LOKIASV2_0141_ESMFold_hypothetical_protein	2hyy-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	2hyy-assembly3.cif.gz_C Human Abl kinase domain in complex with imatinib (STI571, Glivec)	0.126	257	219	32	283	6	262	3.492E-04	92
LOKIASV2_0141_ESMFold_hypothetical_protein	3cpb-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3cpb-assembly2.cif.gz_B Crystal structure of the VEGFR2 kinase domain in complex with a bisamide inhibitor	0.131	248	214	28	274	14	261	9.496E-04	92
LOKIASV2_0141_ESMFold_hypothetical_protein	6fer-assembly6.cif.gz_F	LOKIASV2_0141_ESMFold_hypothetical_protein	6fer-assembly6.cif.gz_F Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	0.131	201	163	32	219	7	207	1.525E-03	92
LOKIASV2_0141_ESMFold_hypothetical_protein	6dkg-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6dkg-assembly1.cif.gz_A Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 13b.	0.135	255	213	28	274	10	264	5.912E-04	92
LOKIASV2_0141_ESMFold_hypothetical_protein	6mzw-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6mzw-assembly1.cif.gz_A TAS-120 covalent complex with FGFR1	0.148	261	210	28	274	14	274	7.298E-04	92
LOKIASV2_0141_ESMFold_hypothetical_protein	6gql-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6gql-assembly2.cif.gz_B Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 35)	0.143	274	210	28	273	12	285	3.879E-04	92
LOKIASV2_0141_ESMFold_hypothetical_protein	6nyb-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6nyb-assembly1.cif.gz_B Structure of a MAPK pathway complex	0.141	217	163	30	220	7	223	5.321E-04	92
LOKIASV2_0141_ESMFold_hypothetical_protein	6pl3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6pl3-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND 2a	0.136	269	211	28	272	10	278	6.924E-04	92
LOKIASV2_0141_ESMFold_hypothetical_protein	6gqk-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6gqk-assembly2.cif.gz_B Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 23)	0.119	272	216	28	273	17	288	3.879E-04	92
LOKIASV2_0141_ESMFold_hypothetical_protein	7vkn-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7vkn-assembly1.cif.gz_A Crystal structure of TrkA (G595R) kinase with repotrectinib	0.116	279	215	31	274	9	287	5.912E-04	92
LOKIASV2_0141_ESMFold_hypothetical_protein	3zos-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3zos-assembly2.cif.gz_B Structure of the DDR1 kinase domain in complex with ponatinib	0.120	293	215	34	278	10	302	8.109E-04	92
LOKIASV2_0141_ESMFold_hypothetical_protein	6mob-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6mob-assembly1.cif.gz_A Crystal structure of KIT1 in complex with DP2976 via co-crystallization	0.135	284	211	28	272	22	305	1.055E-03	92
LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.125	194	161	27	220	4	188	2.325E-03	92
LOKIASV2_0141_ESMFold_hypothetical_protein	8cgc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8cgc-assembly1.cif.gz_A Structure of CSF1R in complex with a pyrollopyrimidine (compound 23)	0.132	274	213	28	273	35	308	8.547E-04	92
LOKIASV2_0141_ESMFold_hypothetical_protein	2pzi-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2pzi-assembly2.cif.gz_B Crystal Structure of Protein kinase PknG from Mycobacterium tuberculosis in Complex with Tetrahydrobenzothiophene AX20017	0.137	247	211	28	274	75	319	6.568E-04	92
LOKIASV2_0141_ESMFold_hypothetical_protein	4ybj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4ybj-assembly1.cif.gz_A Type II Dasatinib Analog Crystallized with c-Src Kinase	0.133	252	212	32	283	5	250	6.232E-04	91
LOKIASV2_0141_ESMFold_hypothetical_protein	4jvg-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	4jvg-assembly3.cif.gz_C B-Raf Kinase in Complex with Birb796	0.138	249	209	28	271	9	257	3.361E-03	91
LOKIASV2_0141_ESMFold_hypothetical_protein	6nvl-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6nvl-assembly3.cif.gz_C FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	0.136	255	212	29	274	7	261	4.543E-04	91
LOKIASV2_0141_ESMFold_hypothetical_protein	4qrc-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4qrc-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 4 in Complex with Ponatinib	0.132	284	216	28	277	13	296	5.321E-04	91
LOKIASV2_0141_ESMFold_hypothetical_protein	5k5x-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5k5x-assembly1.cif.gz_A Crystal structure of human PDGFRA	0.134	300	220	28	282	39	338	6.924E-04	91
LOKIASV2_0141_ESMFold_hypothetical_protein	4jvg-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4jvg-assembly1.cif.gz_B B-Raf Kinase in Complex with Birb796	0.138	227	182	48	274	22	233	1.055E-03	90
LOKIASV2_0141_ESMFold_hypothetical_protein	1uwh-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	1uwh-assembly1.cif.gz_B The complex of wild type B-RAF and BAY439006.	0.139	253	214	28	277	9	261	1.172E-03	90
LOKIASV2_0141_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND	0.126	259	212	31	274	6	264	6.568E-04	90
LOKIASV2_0141_ESMFold_hypothetical_protein	3cp9-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3cp9-assembly2.cif.gz_B Crystal structure of the VEGFR2 kinase domain in complex with a pyridone inhibitor	0.136	253	213	28	274	15	267	1.112E-03	90
LOKIASV2_0141_ESMFold_hypothetical_protein	4xuf-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4xuf-assembly2.cif.gz_B Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)	0.151	265	209	26	272	8	272	1.055E-03	90
LOKIASV2_0141_ESMFold_hypothetical_protein	7juw-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7juw-assembly1.cif.gz_B Crystal Structure of KSR1:MEK1 in complex with AMP-PNP	0.102	262	218	29	272	13	274	5.609E-04	90
LOKIASV2_0141_ESMFold_hypothetical_protein	3a4p-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3a4p-assembly1.cif.gz_A human c-MET kinase domain complexed with 6-benzyloxyquinoline inhibitor	0.113	254	219	28	275	13	266	1.172E-03	90
LOKIASV2_0141_ESMFold_hypothetical_protein	3q6u-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3q6u-assembly1.cif.gz_A Structure of the apo MET receptor kinase in the dually-phosphorylated, activated state	0.116	267	209	5	241	9	275	2.450E-03	90
LOKIASV2_0141_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_B Crystal structure of unactivated c-KIT in complex with compound	0.143	273	210	28	273	23	295	4.543E-04	90
LOKIASV2_0141_ESMFold_hypothetical_protein	7vko-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7vko-assembly1.cif.gz_A Crystal structure of TrkA kinase with repotrectinib	0.127	278	217	26	274	11	288	1.373E-03	90
LOKIASV2_0141_ESMFold_hypothetical_protein	5eak-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5eak-assembly1.cif.gz_A Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	0.148	186	147	28	213	6	179	4.149E-03	90
LOKIASV2_0141_ESMFold_hypothetical_protein	4l45-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4l45-assembly1.cif.gz_A Crystal structures of human p70S6K1-T389E	0.129	184	159	30	213	5	188	2.723E-03	90
LOKIASV2_0141_ESMFold_hypothetical_protein	4l46-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4l46-assembly1.cif.gz_A Crystal structures of human p70S6K1-WT	0.144	189	155	32	213	8	196	4.610E-03	90
LOKIASV2_0141_ESMFold_hypothetical_protein	2pzi-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2pzi-assembly1.cif.gz_A Crystal Structure of Protein kinase PknG from Mycobacterium tuberculosis in Complex with Tetrahydrobenzothiophene AX20017	0.133	247	212	28	274	76	321	5.048E-04	90
LOKIASV2_0141_ESMFold_hypothetical_protein	5fd2-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5fd2-assembly1.cif.gz_A B-Raf wild-type kinase domain in complex with a purinylpyridinylamino-based inhibitor	0.154	209	162	28	220	9	217	1.172E-03	89
LOKIASV2_0141_ESMFold_hypothetical_protein	8pyn-assembly1.cif.gz_AAA	LOKIASV2_0141_ESMFold_hypothetical_protein	8pyn-assembly1.cif.gz_AAA Human IGF1R with inhibitor 56	0.143	263	212	34	281	12	274	1.055E-03	89
LOKIASV2_0141_ESMFold_hypothetical_protein	6wxj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6wxj-assembly1.cif.gz_A CSF1R signaling is a regulator of pathogenesis in progressive MS	0.137	255	211	28	273	23	277	4.310E-04	89
LOKIASV2_0141_ESMFold_hypothetical_protein	6d1z-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6d1z-assembly1.cif.gz_A Crystal structure of Tyrosine-protein kinase receptor in complex with 5-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4(3H)-one Inhibitor	0.156	260	208	28	274	19	278	9.496E-04	89
LOKIASV2_0141_ESMFold_hypothetical_protein	3g0f-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3g0f-assembly1.cif.gz_B KIT kinase domain mutant D816H in complex with sunitinib	0.158	200	163	28	222	25	224	8.672E-03	89
LOKIASV2_0141_ESMFold_hypothetical_protein	5dg5-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5dg5-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH ALTIRATINIB ANALOG DP-4157	0.097	228	197	2	220	4	231	1.608E-03	89
LOKIASV2_0141_ESMFold_hypothetical_protein	3krj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3krj-assembly1.cif.gz_A cFMS tyrosine kinase in complex with 4-Cyano-1H-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-piperidin-4-yl-phenyl)-amide	0.135	284	230	7	273	19	302	1.236E-03	89
LOKIASV2_0141_ESMFold_hypothetical_protein	6t2w-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6t2w-assembly1.cif.gz_A Crystal structure of the CSF1R kinase domain with a dihydropurinone inhibitor (compound 4)	0.117	270	218	26	273	31	300	1.236E-03	89
LOKIASV2_0141_ESMFold_hypothetical_protein	7bmk-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7bmk-assembly1.cif.gz_B ATP-Competitive Partial Antagonists-'PAIR's-Rheostatically Modulate IRE1alpha's Kinase Helix-alphaC to Segregate its RNase-Mediated Biological Outputs	0.150	147	122	37	180	1	147	8.227E-03	89
LOKIASV2_0141_ESMFold_hypothetical_protein	3ii5-assembly3.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3ii5-assembly3.cif.gz_A The Complex of wild-type B-RAF with Pyrazolo pyrimidine inhibitor	0.121	251	216	28	274	9	259	1.525E-03	88
LOKIASV2_0141_ESMFold_hypothetical_protein	3d94-assembly1.cif.gz_A-2	LOKIASV2_0141_ESMFold_hypothetical_protein	3d94-assembly1.cif.gz_A-2 Crystal structure of the insulin-like growth factor-1 receptor kinase in complex with PQIP	0.161	238	197	34	269	12	249	1.303E-03	88
LOKIASV2_0141_ESMFold_hypothetical_protein	3lco-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3lco-assembly1.cif.gz_A Inhibitor Bound to A DFG-Out structure of the Kinase Domain of CSF-1R	0.130	268	213	28	273	23	290	1.236E-03	88
LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly7.cif.gz_G	LOKIASV2_0141_ESMFold_hypothetical_protein	2hak-assembly7.cif.gz_G Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.123	193	152	28	220	5	178	5.399E-03	88
LOKIASV2_0141_ESMFold_hypothetical_protein	4y83-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4y83-assembly2.cif.gz_B Crystal structure of COT kinase domain in complex with 5-(2-amino-5-(quinolin-3-yl)pyridin-3-yl)-1,3,4-oxadiazole-2(3H)-thione	0.117	249	197	12	235	9	257	5.048E-04	88
LOKIASV2_0141_ESMFold_hypothetical_protein	6gqk-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6gqk-assembly1.cif.gz_A Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 23)	0.111	283	221	28	277	22	304	5.609E-04	88
LOKIASV2_0141_ESMFold_hypothetical_protein	3biz-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3biz-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD331618	0.127	239	198	33	271	4	231	2.205E-03	87
LOKIASV2_0141_ESMFold_hypothetical_protein	3c4c-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3c4c-assembly2.cif.gz_B B-Raf Kinase in Complex with PLX4720	0.136	249	209	28	276	9	251	1.695E-03	87
LOKIASV2_0141_ESMFold_hypothetical_protein	3cpc-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3cpc-assembly2.cif.gz_B Crystal structure of the VEGFR2 kinase domain in complex with a pyridone inhibitor	0.150	237	194	46	274	24	260	1.001E-03	87
LOKIASV2_0141_ESMFold_hypothetical_protein	7zw8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7zw8-assembly1.cif.gz_A Identification of M4205 a highly selective inhibitor of cKIT mutations for unresectable metastatic or recurrent GIST	0.125	272	219	28	278	29	300	6.924E-04	87
LOKIASV2_0141_ESMFold_hypothetical_protein	1zmw-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	1zmw-assembly1.cif.gz_B Catalytic and ubiqutin-associated domains of MARK2/PAR-1: T208A/S212A inactive double mutant	0.136	144	120	28	171	5	144	1.468E-02	87
LOKIASV2_0141_ESMFold_hypothetical_protein	3soa-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3soa-assembly1.cif.gz_A Full-length human CaMKII	0.119	286	219	24	273	2	287	3.025E-03	87
LOKIASV2_0141_ESMFold_hypothetical_protein	4yzn-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4yzn-assembly1.cif.gz_A Humanized Roco4 bound to Compound 19	0.110	200	170	36	227	8	207	5.998E-03	86
LOKIASV2_0141_ESMFold_hypothetical_protein	4f0i-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4f0i-assembly2.cif.gz_B Crystal structure of apo TrkA	0.149	276	209	28	274	9	284	1.787E-03	86
LOKIASV2_0141_ESMFold_hypothetical_protein	6d22-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6d22-assembly1.cif.gz_A Crystal structure of Tyrosine-protein kinase receptor	0.135	276	213	28	274	14	289	1.236E-03	86
LOKIASV2_0141_ESMFold_hypothetical_protein	4r7h-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4r7h-assembly1.cif.gz_A Crystal structure of FMS KINASE domain with a small molecular inhibitor, PLX3397	0.127	273	214	28	273	33	305	7.298E-04	86
LOKIASV2_0141_ESMFold_hypothetical_protein	6a32-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6a32-assembly1.cif.gz_A Crystal structure of PDGFRA kinase domain mutant T674I	0.136	288	220	28	283	39	326	1.608E-03	86
LOKIASV2_0141_ESMFold_hypothetical_protein	6w3a-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6w3a-assembly1.cif.gz_A Structure of unphosphorylated IRE1 in complex with G-7658	0.110	214	171	28	220	7	220	9.141E-03	86
LOKIASV2_0141_ESMFold_hypothetical_protein	7pg5-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7pg5-assembly1.cif.gz_A Crystal Structure of PI3Kalpha	0.137	278	211	30	274	732	1009	3.492E-04	86
LOKIASV2_0141_ESMFold_hypothetical_protein	3dtw-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3dtw-assembly2.cif.gz_B Crystal structure of the VEGFR2 kinase domain in complex with a benzisoxazole inhibitor	0.139	253	212	28	274	14	266	1.695E-03	85
LOKIASV2_0141_ESMFold_hypothetical_protein	2vz6-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2vz6-assembly1.cif.gz_A Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	0.088	283	218	34	273	5	287	8.547E-04	85
LOKIASV2_0141_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A Crystal structure of S. rosetta CaMKII kinase domain	0.103	291	230	28	284	10	300	2.205E-03	85
LOKIASV2_0141_ESMFold_hypothetical_protein	3lcs-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3lcs-assembly1.cif.gz_A Crystal Structure of the Anaplastic Lymphoma Kinase Catalytic Domain	0.116	271	217	28	273	20	290	2.092E-03	85
LOKIASV2_0141_ESMFold_hypothetical_protein	5x02-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5x02-assembly1.cif.gz_A Crystal structure of the FLT3 kinase domain bound to the inhibitor FF-10101	0.159	248	204	28	271	37	284	2.450E-03	85
LOKIASV2_0141_ESMFold_hypothetical_protein	4bwx-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4bwx-assembly1.cif.gz_B Structure of Neurospora crassa PAN3 pseudokinase mutant	0.122	256	220	31	281	31	286	6.568E-04	85
LOKIASV2_0141_ESMFold_hypothetical_protein	3vwa-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3vwa-assembly2.cif.gz_B Crystal structure of Cex1p	0.157	272	221	21	283	5	276	1.787E-03	85
LOKIASV2_0141_ESMFold_hypothetical_protein	4nus-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4nus-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with LJH685	0.125	242	210	30	271	10	250	3.361E-03	84
LOKIASV2_0141_ESMFold_hypothetical_protein	2i0v-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2i0v-assembly1.cif.gz_A c-FMS tyrosine kinase in complex with a quinolone inhibitor	0.143	263	205	34	273	37	299	1.525E-03	84
LOKIASV2_0141_ESMFold_hypothetical_protein	4y85-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	4y85-assembly3.cif.gz_C Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	0.113	244	211	28	271	44	282	2.205E-03	84
LOKIASV2_0141_ESMFold_hypothetical_protein	6joj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6joj-assembly1.cif.gz_A Crystal structure of PDGFRA T674I in complex with crenolanib by soaking	0.145	290	180	28	238	39	328	3.734E-03	84
LOKIASV2_0141_ESMFold_hypothetical_protein	7mgk-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	7mgk-assembly3.cif.gz_C TNNI3K complexed with 1-(3,5-dichloro-4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)-3-(3-(trifluoromethyl)phenyl)urea	0.130	246	206	28	273	18	255	2.870E-03	83
LOKIASV2_0141_ESMFold_hypothetical_protein	6vg3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6vg3-assembly1.cif.gz_A Structure of unliganded, inactive PTK7 kinase domain	0.133	272	209	32	273	5	276	2.450E-03	83
LOKIASV2_0141_ESMFold_hypothetical_protein	5lpw-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5lpw-assembly1.cif.gz_A Crystal structure of the apo-BRI1 kinase domain (865-1160)	0.125	276	234	7	274	7	282	3.361E-03	83
LOKIASV2_0141_ESMFold_hypothetical_protein	6ig8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6ig8-assembly1.cif.gz_A Crystal structure of CSF-1R kinase domain with a small molecular inhibitor, JTE-952	0.123	273	215	28	273	25	297	1.695E-03	83
LOKIASV2_0141_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	0.132	251	204	36	271	4	254	6.924E-04	83
LOKIASV2_0141_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_B Kinase and Ubiquitin-associated domains of MARK3/Par-1	0.129	186	158	28	213	13	194	6.665E-03	83
LOKIASV2_0141_ESMFold_hypothetical_protein	6jlr-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6jlr-assembly1.cif.gz_A Crystal structure of wild type MNK2 in complex with inhibitor	0.128	253	217	26	275	10	262	1.985E-03	82
LOKIASV2_0141_ESMFold_hypothetical_protein	3krl-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3krl-assembly1.cif.gz_A cFMS Tyrosine kinase in complex with 5-Cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2-piperidin-1-yl-phenyl]-amide	0.142	260	209	28	272	21	280	2.092E-03	82
LOKIASV2_0141_ESMFold_hypothetical_protein	3ctj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3ctj-assembly1.cif.gz_A Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a aminopyridine based inhibitor	0.097	213	187	7	219	1	208	7.805E-03	82
LOKIASV2_0141_ESMFold_hypothetical_protein	4y83-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4y83-assembly1.cif.gz_A Crystal structure of COT kinase domain in complex with 5-(2-amino-5-(quinolin-3-yl)pyridin-3-yl)-1,3,4-oxadiazole-2(3H)-thione	0.118	247	186	17	228	10	256	1.608E-03	82
LOKIASV2_0141_ESMFold_hypothetical_protein	4l43-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4l43-assembly1.cif.gz_A Crystal structures of human p70S6K1-T389A (form I)	0.139	186	153	28	213	10	188	1.016E-02	82
LOKIASV2_0141_ESMFold_hypothetical_protein	7d5o-assembly2.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7d5o-assembly2.cif.gz_A C-Src in complex with TAS-120	0.121	252	213	32	283	7	249	3.361E-03	81
LOKIASV2_0141_ESMFold_hypothetical_protein	7cbx-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7cbx-assembly1.cif.gz_A Crystal structure of MAP2K7 complexed with a covalent inhibitor 12	0.122	267	212	32	274	14	280	3.936E-03	81
LOKIASV2_0141_ESMFold_hypothetical_protein	4y85-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4y85-assembly2.cif.gz_B Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	0.108	277	231	12	271	9	285	1.236E-03	81
LOKIASV2_0141_ESMFold_hypothetical_protein	3tku-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3tku-assembly1.cif.gz_A MRCK beta in complex with fasudil	0.124	242	188	13	228	56	297	6.665E-03	81
LOKIASV2_0141_ESMFold_hypothetical_protein	7mgj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7mgj-assembly1.cif.gz_A TNNI3K complexed with N-methyl-4-(4-(3-(3-(trifluoromethyl) phenyl) ureido) phenoxy)picolinamide	0.130	246	208	28	273	18	257	4.610E-03	80
LOKIASV2_0141_ESMFold_hypothetical_protein	2ogv-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2ogv-assembly1.cif.gz_A Crystal Structure of the Autoinhibited Human c-Fms Kinase Domain	0.124	273	215	28	273	39	311	3.188E-03	80
LOKIASV2_0141_ESMFold_hypothetical_protein	4l44-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4l44-assembly1.cif.gz_A Crystal structures of human p70S6K1-T389A (form II)	0.136	193	157	34	216	9	201	1.631E-02	80
LOKIASV2_0141_ESMFold_hypothetical_protein	5itd-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5itd-assembly1.cif.gz_A Crystal structure of PI3K alpha with PI3K delta inhibitor	0.136	276	211	30	274	707	982	5.609E-04	80
LOKIASV2_0141_ESMFold_hypothetical_protein	1s9i-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	1s9i-assembly1.cif.gz_B X-ray structure of the human mitogen-activated protein kinase kinase 2 (MEK2)in a complex with ligand and MgATP	0.159	184	152	30	213	8	189	1.016E-02	79
LOKIASV2_0141_ESMFold_hypothetical_protein	3eta-assembly3.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3eta-assembly3.cif.gz_A Kinase domain of insulin receptor complexed with a pyrrolo pyridine inhibitor	0.141	253	205	30	269	1	253	2.450E-03	79
LOKIASV2_0141_ESMFold_hypothetical_protein	6hh1-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6hh1-assembly1.cif.gz_A Structure of c-Kit with allosteric inhibitor 3G8	0.125	277	214	28	273	24	300	2.205E-03	79
LOKIASV2_0141_ESMFold_hypothetical_protein	7n91-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7n91-assembly2.cif.gz_B P70 S6K1 IN COMPLEX WITH MSC2317067A-1	0.133	184	155	30	213	1	180	9.141E-03	79
LOKIASV2_0141_ESMFold_hypothetical_protein	4bwk-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4bwk-assembly1.cif.gz_B Structure of Neurospora crassa PAN3 pseudokinase	0.105	357	223	31	280	30	386	3.543E-03	79
LOKIASV2_0141_ESMFold_hypothetical_protein	4bwk-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4bwk-assembly1.cif.gz_A Structure of Neurospora crassa PAN3 pseudokinase	0.096	254	226	31	281	30	283	1.985E-03	79
LOKIASV2_0141_ESMFold_hypothetical_protein	4y83-assembly3.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	4y83-assembly3.cif.gz_C Crystal structure of COT kinase domain in complex with 5-(2-amino-5-(quinolin-3-yl)pyridin-3-yl)-1,3,4-oxadiazole-2(3H)-thione	0.130	191	164	47	235	62	252	5.691E-03	78
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8pqj-assembly1.cif.gz_A PDGFRA wild-type kinase domain	0.145	286	218	28	283	34	319	5.691E-03	78
LOKIASV2_0141_ESMFold_hypothetical_protein	4fr4-assembly5.cif.gz_E	LOKIASV2_0141_ESMFold_hypothetical_protein	4fr4-assembly5.cif.gz_E Crystal structure of human serine/threonine-protein kinase 32A (YANK1)	0.124	244	209	28	271	9	248	3.734E-03	78
LOKIASV2_0141_ESMFold_hypothetical_protein	8dwn-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8dwn-assembly1.cif.gz_A Crystal structure of bis-phosphorylated insulin receptor kinase domain	0.136	241	205	32	269	6	246	3.543E-03	77
LOKIASV2_0141_ESMFold_hypothetical_protein	5sw8-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5sw8-assembly1.cif.gz_A Crystal structure of PI3Kalpha in complex with fragments 7 and 11	0.138	279	209	31	274	746	1024	6.924E-04	77
LOKIASV2_0141_ESMFold_hypothetical_protein	5fxr-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5fxr-assembly1.cif.gz_A IGFR-1R complex with a pyrimidine inhibitor.	0.105	248	215	34	274	18	265	3.936E-03	76
LOKIASV2_0141_ESMFold_hypothetical_protein	8pqk-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8pqk-assembly1.cif.gz_A APO crystal structure of PDGFRA-T674I kinase domain	0.136	286	219	28	282	30	315	5.691E-03	76
LOKIASV2_0141_ESMFold_hypothetical_protein	4hvs-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4hvs-assembly1.cif.gz_A Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX647	0.139	285	211	28	273	41	325	5.691E-03	76
LOKIASV2_0141_ESMFold_hypothetical_protein	8ilv-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8ilv-assembly1.cif.gz_A Cryo-EM structure of PI3Kalpha in complex with compound 18	0.138	263	217	30	282	701	963	1.447E-03	76
LOKIASV2_0141_ESMFold_hypothetical_protein	4a55-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4a55-assembly1.cif.gz_A Crystal structure of p110alpha in complex with iSH2 of p85alpha and the inhibitor PIK-108	0.151	271	213	30	281	711	981	1.172E-03	76
LOKIASV2_0141_ESMFold_hypothetical_protein	2i0y-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2i0y-assembly1.cif.gz_A cFMS tyrosine kinase (FGF KID) in complex with an arylamide inhibitor	0.131	244	210	28	271	24	266	1.071E-02	75
LOKIASV2_0141_ESMFold_hypothetical_protein	8j5x-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8j5x-assembly1.cif.gz_A The crystal structure of TrkA(G595R) kinase in complex with N-(3-cyclopropyl-5-((4-methylpiperazin-1-yl)methyl)phenyl)-4^6-methyl-14-oxo-5-oxa-13-aza-1(3,6)-imidazo[1,2-b]pyridazina-4(1,3)-benzenacyclotetradecaphan-2-yne-4^5-carboxamide	0.111	274	217	28	272	10	283	7.405E-03	74
LOKIASV2_0141_ESMFold_hypothetical_protein	4bbm-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4bbm-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN WITH BOUND TCS 2312	0.151	273	201	34	271	2	274	1.883E-03	74
LOKIASV2_0141_ESMFold_hypothetical_protein	7byk-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7byk-assembly1.cif.gz_A Crystal structure of the Legionella pneumophila LegK7 effector kinase	0.119	288	231	12	274	145	432	4.373E-03	74
LOKIASV2_0141_ESMFold_hypothetical_protein	4mne-assembly1.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	4mne-assembly1.cif.gz_D Crystal structure of the BRAF:MEK1 complex	0.161	182	149	36	213	3	184	1.631E-02	73
LOKIASV2_0141_ESMFold_hypothetical_protein	3my0-assembly13.cif.gz_M	LOKIASV2_0141_ESMFold_hypothetical_protein	3my0-assembly13.cif.gz_M Crystal structure of the ACVRL1 (ALK1) kinase domain bound to LDN-193189	0.144	289	211	28	274	8	296	5.691E-03	73
LOKIASV2_0141_ESMFold_hypothetical_protein	4y85-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4y85-assembly1.cif.gz_A Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	0.113	242	191	12	227	9	250	4.610E-03	73
LOKIASV2_0141_ESMFold_hypothetical_protein	5iu2-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5iu2-assembly1.cif.gz_A Discovery of imidazoquinolines as a novel class of potent, selective and in vivo efficacious COT kinase inhibitors	0.116	244	214	28	271	50	292	3.543E-03	73
LOKIASV2_0141_ESMFold_hypothetical_protein	3c51-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3c51-assembly1.cif.gz_B Crystal structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 3.55A	0.112	216	181	12	216	119	334	2.486E-02	73
LOKIASV2_0141_ESMFold_hypothetical_protein	5o2b-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	5o2b-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in a complex with the inhibitor PP-121	0.115	223	156	37	213	6	228	1.071E-02	72
LOKIASV2_0141_ESMFold_hypothetical_protein	7n93-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7n93-assembly1.cif.gz_A P70 S6K1 IN COMPLEX WITH MSC2363318A-1	0.144	209	158	32	217	1	209	3.594E-02	71
LOKIASV2_0141_ESMFold_hypothetical_protein	5iu2-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5iu2-assembly2.cif.gz_B Discovery of imidazoquinolines as a novel class of potent, selective and in vivo efficacious COT kinase inhibitors	0.132	260	205	35	271	53	312	5.998E-03	71
LOKIASV2_0141_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_B Crystal Structure of ROCK 1 bound to YB-15-QD37	0.101	233	184	13	218	49	281	1.016E-02	71
LOKIASV2_0141_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	0.120	205	175	32	236	4	203	1.189E-02	69
LOKIASV2_0141_ESMFold_hypothetical_protein	6jok-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6jok-assembly1.cif.gz_A Crystal structure of PDGFRA in complex with sunitinib by soaking	0.124	295	223	28	282	37	331	7.805E-03	69
LOKIASV2_0141_ESMFold_hypothetical_protein	4i4f-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4i4f-assembly1.cif.gz_A Structure of Focal Adhesion Kinase catalytic domain in complex with an allosteric binding pyrazolobenzothiazine compound.	0.133	250	212	28	277	7	251	2.014E-02	67
LOKIASV2_0141_ESMFold_hypothetical_protein	6t28-assembly1.cif.gz_AAA	LOKIASV2_0141_ESMFold_hypothetical_protein	6t28-assembly1.cif.gz_AAA Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 19 (CS640)	0.103	260	222	25	273	9	268	4.677E-02	64
LOKIASV2_0141_ESMFold_hypothetical_protein	8bfs-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8bfs-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) in complex with FZ326	0.116	260	216	29	273	12	271	4.210E-02	64
LOKIASV2_0141_ESMFold_hypothetical_protein	7byk-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	7byk-assembly2.cif.gz_B Crystal structure of the Legionella pneumophila LegK7 effector kinase	0.108	304	243	12	284	149	452	1.468E-02	63
LOKIASV2_0141_ESMFold_hypothetical_protein	6k5l-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6k5l-assembly1.cif.gz_B The crystal structure of isocitrate dehydrogenase kinase/phosphatase wtih two Mn2+ from E. coli	0.081	249	196	13	226	288	536	1.393E-02	62
LOKIASV2_0141_ESMFold_hypothetical_protein	6t29-assembly1.cif.gz_AAA	LOKIASV2_0141_ESMFold_hypothetical_protein	6t29-assembly1.cif.gz_AAA Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 18 (CS587)	0.106	260	218	29	273	12	271	7.128E-02	57
LOKIASV2_0141_ESMFold_hypothetical_protein	6k5l-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6k5l-assembly1.cif.gz_A The crystal structure of isocitrate dehydrogenase kinase/phosphatase wtih two Mn2+ from E. coli	0.073	252	198	13	227	296	547	3.594E-02	57
LOKIASV2_0141_ESMFold_hypothetical_protein	8bfm-assembly1.cif.gz_A-2	LOKIASV2_0141_ESMFold_hypothetical_protein	8bfm-assembly1.cif.gz_A-2 Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) in complex with FZ331	0.110	255	221	25	273	9	263	8.799E-02	55
LOKIASV2_0141_ESMFold_hypothetical_protein	3ff0-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3ff0-assembly1.cif.gz_A Crystal structure of a phenazine biosynthesis-related protein (phzb2) from pseudomonas aeruginosa at 1.90 A resolution	0.100	48	41	29	74	82	129	4.568E+00	30
LOKIASV2_0141_ESMFold_hypothetical_protein	2lnj-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2lnj-assembly1.cif.gz_A Solution Structure of Cyanobacterial PsbP (CyanoP) from Synechocystis sp. PCC 6803	0.075	73	67	3	75	66	138	6.604E+00	29
LOKIASV2_0141_ESMFold_hypothetical_protein	3ff0-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	3ff0-assembly1.cif.gz_B Crystal structure of a phenazine biosynthesis-related protein (phzb2) from pseudomonas aeruginosa at 1.90 A resolution	0.094	49	42	29	75	73	121	9.059E+00	28
LOKIASV2_0141_ESMFold_hypothetical_protein	2xcr-assembly2.cif.gz_S	LOKIASV2_0141_ESMFold_hypothetical_protein	2xcr-assembly2.cif.gz_S The 3.5A crystal structure of the catalytic core (B'A' region) of Staphylococcus aureus DNA Gyrase complexed with GSK299423 and DNA	0.108	240	206	43	274	465	704	1.207E-01	27
LOKIASV2_0141_ESMFold_hypothetical_protein	6qx2-assembly2.cif.gz_J	LOKIASV2_0141_ESMFold_hypothetical_protein	6qx2-assembly2.cif.gz_J 3.4A structure of benzoisoxazole 3 with S.aureus DNA gyrase and DNA	0.126	243	206	43	279	227	469	9.275E-02	26
LOKIASV2_0141_ESMFold_hypothetical_protein	4f3l-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4f3l-assembly1.cif.gz_A Crystal Structure of the Heterodimeric CLOCK:BMAL1 Transcriptional Activator Complex	0.212	45	35	32	76	137	181	5.639E+00	25
LOKIASV2_0141_ESMFold_hypothetical_protein	6w4o-assembly1.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	6w4o-assembly1.cif.gz_C CaMKII alpha-30 Cryo-EM reconstruction	0.113	43	36	29	71	66	107	6.962E+00	24
LOKIASV2_0141_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_E	LOKIASV2_0141_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_E Crystal structure of the human CaMKII-alpha hub	0.100	48	41	29	75	64	111	7.338E+00	23
LOKIASV2_0141_ESMFold_hypothetical_protein	2f86-assembly1.cif.gz_H	LOKIASV2_0141_ESMFold_hypothetical_protein	2f86-assembly1.cif.gz_H The Association Domain of C. elegans CaMKII	0.068	43	38	29	71	70	111	8.594E+00	23
LOKIASV2_0141_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_C-2	LOKIASV2_0141_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_C-2 Crystal structure of the human CaMKII-alpha hub	0.113	43	36	29	71	72	113	8.153E+00	23
LOKIASV2_0141_ESMFold_hypothetical_protein	8bfn-assembly1.cif.gz_G	LOKIASV2_0141_ESMFold_hypothetical_protein	8bfn-assembly1.cif.gz_G E. coli Wadjet JetABC dimer of dimers	0.106	239	199	44	282	119	342	4.502E-01	23
LOKIASV2_0141_ESMFold_hypothetical_protein	2rgq-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2rgq-assembly1.cif.gz_A Crystal structure of a protein of unknown function with a cystatin-like fold (npun_r3134) from nostoc punctiforme pcc 73102 at 1.80 A resolution	0.111	62	52	16	77	55	114	6.604E+00	22
LOKIASV2_0141_ESMFold_hypothetical_protein	7z9g-assembly1.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	7z9g-assembly1.cif.gz_C E.coli gyrase holocomplex with 217 bp DNA and Albi-2	0.111	276	208	44	278	230	505	3.647E-01	22
LOKIASV2_0141_ESMFold_hypothetical_protein	2rfr-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	2rfr-assembly1.cif.gz_A Crystal structure of an ntf2-like protein with a cystatin-like fold (saro_3722) from novosphingobium aromaticivorans dsm at 1.16 A resolution	0.052	52	48	26	77	78	129	8.594E+00	21
LOKIASV2_0141_ESMFold_hypothetical_protein	5iv8-assembly2.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	5iv8-assembly2.cif.gz_D The LPS Transporter LptDE from Klebsiella pneumoniae, core complex	0.126	69	52	29	88	56	124	7.735E+00	20
LOKIASV2_0141_ESMFold_hypothetical_protein	6rku-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6rku-assembly1.cif.gz_A E. coli DNA Gyrase - DNA binding and cleavage domain in State 1	0.121	270	206	44	278	230	499	5.558E-01	20
LOKIASV2_0141_ESMFold_hypothetical_protein	7urz-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7urz-assembly1.cif.gz_A Hexadecameric hub domain of CaMKII beta	0.090	53	45	26	75	55	107	9.059E+00	19
LOKIASV2_0141_ESMFold_hypothetical_protein	4kwy-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	4kwy-assembly1.cif.gz_A Crystal structure of a putative lipoprotein (CC_3750) from Caulobacter crescentus CB15 at 2.40 A resolution	0.105	57	43	29	77	45	101	8.153E+00	19
LOKIASV2_0141_ESMFold_hypothetical_protein	6qbd-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6qbd-assembly2.cif.gz_B Crystal structure of NLPPya P41A, D44N, N48E mutant	0.131	38	32	38	75	72	109	6.962E+00	19
LOKIASV2_0141_ESMFold_hypothetical_protein	3cyg-assembly2.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	3cyg-assembly2.cif.gz_A Crystal structure of an uncharacterized protein from Fervidobacterium nodosum Rt17-B1	0.070	95	83	12	101	54	148	9.059E+00	19
LOKIASV2_0141_ESMFold_hypothetical_protein	6yjz-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6yjz-assembly1.cif.gz_B Crystal structure of mouse pyridoxal kinase in apo form	0.052	74	51	41	95	191	264	9.059E+00	19
LOKIASV2_0141_ESMFold_hypothetical_protein	1um2-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	1um2-assembly2.cif.gz_B Crystal Structure of the Vma1-Derived Endonuclease with the Ligated Extein Segment	0.108	90	63	27	116	70	141	4.815E+00	19
LOKIASV2_0141_ESMFold_hypothetical_protein	4kz1-assembly1.cif.gz_A-2	LOKIASV2_0141_ESMFold_hypothetical_protein	4kz1-assembly1.cif.gz_A-2 Crystal structure of the soluble domain of VirB8 from Bartonella grahamii	0.144	84	62	13	86	39	122	8.153E+00	18
LOKIASV2_0141_ESMFold_hypothetical_protein	5nnw-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	5nnw-assembly2.cif.gz_B NLPPya in complex with glucosamine	0.135	37	29	38	74	71	105	6.266E+00	18
LOKIASV2_0141_ESMFold_hypothetical_protein	7bt5-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7bt5-assembly1.cif.gz_A Crystal structure of plasmodium LysRS complexing with an antitumor compound	0.098	181	125	10	149	174	354	5.639E+00	17
LOKIASV2_0141_ESMFold_hypothetical_protein	7nyw-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7nyw-assembly1.cif.gz_A Cryo-EM structure of the MukBEF-MatP-DNA head module	0.091	286	217	44	283	97	382	1.046E+00	17
LOKIASV2_0141_ESMFold_hypothetical_protein	7o3x-assembly1.cif.gz_E	LOKIASV2_0141_ESMFold_hypothetical_protein	7o3x-assembly1.cif.gz_E Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity	0.104	201	126	81	281	4	145	4.111E+00	16
LOKIASV2_0141_ESMFold_hypothetical_protein	8dk3-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	8dk3-assembly1.cif.gz_B CryoEM structure of Pseudomonas aeruginosa PA14 JetC ATPase domain bound to DNA and cWHD domain of JetA	0.092	238	186	36	273	102	307	2.844E+00	16
LOKIASV2_0141_ESMFold_hypothetical_protein	6hcv-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6hcv-assembly1.cif.gz_A Crystal Structure of Lysyl-tRNA Synthetase from Plasmodium falciparum complexed with a chromone ligand	0.103	188	134	11	160	172	359	5.639E+00	16
LOKIASV2_0141_ESMFold_hypothetical_protein	8dk1-assembly1.cif.gz_D	LOKIASV2_0141_ESMFold_hypothetical_protein	8dk1-assembly1.cif.gz_D CryoEM structure of JetABC (head construct) from Pseudomonas aeruginosa PA14	0.097	257	200	26	282	70	291	2.428E+00	16
LOKIASV2_0141_ESMFold_hypothetical_protein	8oip-assembly1.cif.gz_Ae	LOKIASV2_0141_ESMFold_hypothetical_protein	8oip-assembly1.cif.gz_Ae 28S mammalian mitochondrial small ribosomal subunit with mtRF1 and P-site tRNA	0.146	212	156	72	283	302	485	5.350E+00	16
LOKIASV2_0141_ESMFold_hypothetical_protein	1jva-assembly2.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	1jva-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE VMA1-DERIVED ENDONUCLEASE BEARING THE N AND C EXTEIN PROPEPTIDES	0.105	229	178	27	226	77	305	2.844E+00	15
LOKIASV2_0141_ESMFold_hypothetical_protein	8dk2-assembly1.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	8dk2-assembly1.cif.gz_C CryoEM structure of Pseudomonas aeruginosa PA14 JetABC in an unclamped state trapped in ATP dependent dimeric form	0.078	281	228	36	283	102	382	1.770E+00	15
LOKIASV2_0141_ESMFold_hypothetical_protein	4ycv-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	4ycv-assembly2.cif.gz_C Crystal structure of cladosporin in complex with plasmodium lysyl-tRNA synthetase	0.094	181	124	12	149	176	356	9.059E+00	14
LOKIASV2_0141_ESMFold_hypothetical_protein	8dk3-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	8dk3-assembly1.cif.gz_A CryoEM structure of Pseudomonas aeruginosa PA14 JetC ATPase domain bound to DNA and cWHD domain of JetA	0.104	183	132	36	218	102	249	5.944E+00	13
LOKIASV2_0141_ESMFold_hypothetical_protein	6l4q-assembly1.cif.gz_B	LOKIASV2_0141_ESMFold_hypothetical_protein	6l4q-assembly1.cif.gz_B Crystal Structure of Lysyl-tRNA Synthetase from Plasmodium falciparum complexed with L-lysine and Clado-B	0.120	121	99	29	149	243	356	7.735E+00	13
LOKIASV2_0141_ESMFold_hypothetical_protein	6bni-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	6bni-assembly1.cif.gz_A Crystal Structure of Lysyl-tRNA Synthetase from Cryptosporidium parvum complexed with L-lysine and Adenosine	0.114	220	148	48	215	247	466	6.962E+00	13
LOKIASV2_0141_ESMFold_hypothetical_protein	7dkv-assembly1.cif.gz_A	LOKIASV2_0141_ESMFold_hypothetical_protein	7dkv-assembly1.cif.gz_A Crystal structure of TxGH116 E441A nucleophile mutant from Thermoanaerobacterium xylanolyticum with cellotriose	0.083	409	227	29	277	204	612	9.059E+00	13
LOKIASV2_0141_ESMFold_hypothetical_protein	7zog-assembly2.cif.gz_C	LOKIASV2_0141_ESMFold_hypothetical_protein	7zog-assembly2.cif.gz_C Crystal structure of Cryptosporidium parvum -Plasmodium falciparum mutant lysyl tRNA synthetase in complex with inhibitor	0.131	140	109	10	149	227	352	8.594E+00	12
